Abstract
Nitro-oxidative stress and lowered antioxidant defences play a key role in neuropsychiatric disorders such as major depression, bipolar disorder and schizophrenia. The first part of this paper details mitochondrial antioxidant mechanisms and their importance in reactive oxygen species (ROS) detoxification, including details of NO networks, the roles of H2O2 and the thioredoxin/peroxiredoxin system, and the relationship between mitochondrial respiration and NADPH production. The second part highlights and identifies the causes of the multiple pathological sequelae arising from self-amplifying increases in mitochondrial ROS production and bioenergetic failure. Particular attention is paid to NAD+ depletion as a core cause of pathology; detrimental effects of raised ROS and reactive nitrogen species on ATP and NADPH generation; detrimental effects of oxidative and nitrosative stress on the glutathione and thioredoxin systems; and the NAD+-induced signalling cascade, including the roles of SIRT1, SIRT3, PGC-1α, the FOXO family of transcription factors, Nrf1 and Nrf2. The third part discusses proposed therapeutic interventions aimed at mitigating such pathology, including the use of the NAD+ precursors nicotinamide mononucleotide and nicotinamide riboside, both of which rapidly elevate levels of NAD+ in the brain and periphery following oral administration; coenzyme Q10 which, when given with the aim of improving mitochondrial function and reducing nitro-oxidative stress in the brain, may be administered via the use of mitoquinone, which is in essence ubiquinone with an attached triphenylphosphonium cation; and N-acetylcysteine, which is associated with improved mitochondrial function in the brain and produces significant decreases in oxidative and nitrosative stress in a dose-dependent manner.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2011) Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis/chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression. Neuro endocrinol Lett 32(2):133–140
Maes M, Landucci Bonifacio K, Morelli NR, Vargas HO, Barbosa DS, Carvalho AF, Nunes SOV (2019) Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types I and II bipolar disorder. Mol Neurobiol 56(1):141–156. https://doi.org/10.1007/s12035-018-1051-7
Berk M, Conus P, Kapczinski F, Andreazza AC, Yucel M, Wood SJ, Pantelis C, Malhi GS, Dodd S, Bechdolf A, Amminger GP, Hickie IB, McGorry PD (2010) From neuroprogression to neuroprotection: implications for clinical care. Med J Aust 193(S4):S36–40
Liu M-L, Zhang X-T, Du X-Y, Fang Z, Liu Z, Xu Y, Zheng P, Xu X-J, Cheng P-F, Huang T, Bai S-J, Zhao L-B, Qi Z-G, Shao W-H, Xie P (2015) Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study. J Transl Med 13:226–226. https://doi.org/10.1186/s12967-015-0540-y
Solanki N, Alkadhi I, Atrooz F, Patki G, Salim S (2015) Grape powder prevents cognitive, behavioral, and biochemical impairments in a rat model of posttraumatic stress disorder. Nutr Res 35(1):65–75. https://doi.org/10.1016/j.nutres.2014.11.008
Solanki N, Salvi A, Patki G, Salim S (2017) Modulating oxidative stress relieves stress-induced behavioral and cognitive impairments in rats. Int J Neuropsychopharmacol 20(7):550–561. https://doi.org/10.1093/ijnp/pyx017
Salim S (2014) Oxidative stress and psychological disorders. Curr Neuropharmacol 12(2):140–147. https://doi.org/10.2174/1570159X11666131120230309
Salim S (2017) Oxidative stress and the central nervous system. J Pharmacol Exp Ther 360(1):201–205. https://doi.org/10.1124/jpet.116.237503
Fraguas D, Díaz-Caneja CM, Ayora M, Hernández-Álvarez F, Rodríguez-Quiroga A, Recio S, Leza JC, Arango C (2019) Oxidative stress and inflammation in first-episode psychosis: a systematic review and meta-analysis. Schizophr Bull 45(4):742–751. https://doi.org/10.1093/schbul/sby125
Knorr U, Simonsen AH, Roos P, Weimann A, Henriksen T, Christensen E-M, Vinberg M, Mikkelsen RL, Kirkegaard T, Jensen RN, Akhøj M, Forman J, Poulsen HE, Hasselbalch SG, Kessing LV (2019) Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study. Transl Psychiatry 9(1):325. https://doi.org/10.1038/s41398-019-0664-6
Black CN, Bot M, Scheffer PG, Cuijpers P, Penninx BW (2015) Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology. https://doi.org/10.1016/j.psyneuen.2014.09.025
Michel TM, Pülschen D, Thome J (2012) The role of oxidative stress in depressive disorders. Curr Pharm Des 18(36):5890–5899. https://doi.org/10.2174/138161212803523554
Singh N, McMahon H, Bilderbeck A, Reed ZE, Tunbridge E, Brett D, Geddes JR, Churchill GC, Goodwin GM (2019) Plasma glutathione suggests oxidative stress is equally present in early- and late-onset bipolar disorder. Bipolar Disord 21(1):61–67. https://doi.org/10.1111/bdi.12640
Morris G, Puri BK, Walker AJ, Berk M, Walder K, Bortolasci CC, Marx W, Carvalho AF, Maes M (2019) The compensatory antioxidant response system with a focus on neuroprogressive disorders. Prog Neuro-psychopharmacol Biol Psychiatry. https://doi.org/10.1016/j.pnpbp.2019.109708
Leonard B, Maes M (2012) Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 36(2):764–785. https://doi.org/10.1016/j.neubiorev.2011.12.005
Morris G, Walder K, McGee SL, Dean OM, Tye SJ, Maes M, Berk M (2017) A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev 74(Pt A):1–20. https://doi.org/10.1016/j.neubiorev.2017.01.014
Callaly E, Walder K, Morris G, Maes M, Debnath M, Berk M (2015) Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy. Mini Rev Med Chem 15(5):355–365
Maes M, Galecki P, Chang YS, Berk M (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35(3):676–692. https://doi.org/10.1016/j.pnpbp.2010.05.004
Owe-Larsson B, Ekdahl K, Edbom T, Osby U, Karlsson H, Lundberg C, Lundberg M (2011) Increased plasma levels of thioredoxin-1 in patients with first episode psychosis and long-term schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35(4):1117–1121. https://doi.org/10.1016/j.pnpbp.2011.03.012
Nasyrova RF, Ivashchenko DV, Ivanov MV, Neznanov NG (2015) Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects. Front Physiol. https://doi.org/10.3389/fphys.2015.00139
Zhang XY, Chen DC, Xiu MH, Wang F, Qi LY, Sun HQ, Chen S, He SC, Wu GY, Haile CN, Kosten TA, Lu L, Kosten TR (2009) The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients. Schizophr Res 113(2):151–157. https://doi.org/10.1016/j.schres.2009.05.016
Aydin EP, Genc A, Dalkiran M, Uyar ET, Deniz I, Ozer OA, Karamustafalioglu KO (2018) Thioredoxin is not a marker for treatment-resistance depression but associated with cognitive function: an rTMS study. Prog Neuropsychopharmacol Biol Psychiatry 80(Pt C):322–328. https://doi.org/10.1016/j.pnpbp.2017.04.025
Bas A, Gultekin G, Incir S, Bas TO, Emul M, Duran A (2017) Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics. Psychiatry Res 247:84–89. https://doi.org/10.1016/j.psychres.2016.11.021
Genc K, Genc S (2009) Oxidative stress and dysregulated Nrf2 activation in the pathogenesis of schizophrenia. Biosci Hypotheses 2(1):16–18. https://doi.org/10.1016/j.bihy.2008.10.005
Genc A, Kalelioglu T, Karamustafalioglu N, Tasdemir A, Gungor FC, Genc ES, Incir S, Ilnem C, Emul M (2015) Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment. Psychiatry Clin Neurosci 69(6):344–350. https://doi.org/10.1111/pcn.12244
Nucifora LG, Tanaka T, Hayes LN, Kim M, Lee BJ, Matsuda T, Nucifora FC Jr, Sedlak T, Mojtabai R, Eaton W, Sawa A (2017) Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry. Transl Psychiatry 7(8):e1215–e1215. https://doi.org/10.1038/tp.2017.178
Freed RD, Hollenhorst CN, Weiduschat N, Mao X, Kang G, Shungu DC, Gabbay V (2017) A pilot study of cortical glutathione in youth with depression. Psychiatry Res 270:54–60. https://doi.org/10.1016/j.pscychresns.2017.10.001
Lapidus KAB, Gabbay V, Mao X, Johnson A, Murrough JW, Mathew SJ, Shungu DC (2014) In vivo 1H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder. Neurosci Lett 569:74–79. https://doi.org/10.1016/j.neulet.2014.03.056
Gawryluk JW, Wang J-F, Andreazza AC, Shao L, Young LT (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14(1):123–130. https://doi.org/10.1017/s1461145710000805
Yao JK, Reddy RD, van Kammen DP (1999) Human plasma glutathione peroxidase and symptom severity in schizophrenia. Biol Psychiatry 45(11):1512–1515. https://doi.org/10.1016/s0006-3223(98)00184-x
Martin-Hernandez D, Caso JR, Javier Meana J, Callado LF, Madrigal JLM, Garcia-Bueno B, Leza JC (2018) Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants. J Neuroinflamm 15(1):251. https://doi.org/10.1186/s12974-018-1294-2
Zhang JC, Yao W, Dong C, Han M, Shirayama Y, Hashimoto K (2018) Keap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress. Eur Arch Psychiatry Clin Neurosci 268(8):865–870. https://doi.org/10.1007/s00406-017-0848-0
Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS (2010) Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci USA 107(6):2669–2674. https://doi.org/10.1073/pnas.0910658107
Elhaik E, Zandi P (2015) Dysregulation of the NF-kappaB pathway as a potential inducer of bipolar disorder. J Psychiatr Res 70:18–27. https://doi.org/10.1016/j.jpsychires.2015.08.009
Volk DW, Moroco AE, Roman KM, Edelson JR, Lewis DA (2019) The role of the nuclear factor-kappaB transcriptional complex in cortical immune activation in schizophrenia. Biol Psychiatry 85(1):25–34. https://doi.org/10.1016/j.biopsych.2018.06.015
Wardyn JD, Ponsford AH, Sanderson CM (2015) Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways. Biochem Soc Trans 43(4):621–626. https://doi.org/10.1042/BST20150014
Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A (2013) Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 25(10):1939–1948. https://doi.org/10.1016/j.cellsig.2013.06.007
Albensi BC (2019) What is nuclear factor kappa B (NF-κB) doing in and to the mitochondrion? Front Cell Dev Biol. https://doi.org/10.3389/fcell.2019.00154
Kim Y, Santos R, Gage FH, Marchetto MC (2017) Molecular mechanisms of bipolar disorder: progress made and future challenges. Front Cell Neurosci. https://doi.org/10.3389/fncel.2017.00030
Scaini G, Rezin GT, Carvalho AF, Streck EL, Berk M, Quevedo J (2016) Mitochondrial dysfunction in bipolar disorder: evidence, pathophysiology and translational implications. Neurosci Biobehav Rev 68:694–713. https://doi.org/10.1016/j.neubiorev.2016.06.040
Gassen NC, Rein T (2019) Is there a role of autophagy in depression and antidepressant action? Front Psychiatry. https://doi.org/10.3389/fpsyt.2019.00337
Bansal Y, Kuhad A (2016) Mitochondrial dysfunction in depression. Curr Neuropharmacol 14(6):610–618. https://doi.org/10.2174/1570159X14666160229114755
Flippo KH, Strack S (2017) An emerging role for mitochondrial dynamics in schizophrenia. Schizophr Res 187:26–32. https://doi.org/10.1016/j.schres.2017.05.003
Roberts RC (2017) Postmortem studies on mitochondria in schizophrenia. Schizophr Res 187:17–25. https://doi.org/10.1016/j.schres.2017.01.056
Morris G, Walder K, Carvalho AF, Tye SJ, Lucas K, Berk M, Maes M (2018) The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases. Neurosci Biobehav Rev 84:453–469. https://doi.org/10.1016/j.neubiorev.2017.07.017
Klauser P, Xin L, Fournier M, Griffa A, Cleusix M, Jenni R, Cuenod M, Gruetter R, Hagmann P, Conus P, Baumann PS, Do KQ (2018) N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial. Transl Psychiatry 8(1):220. https://doi.org/10.1038/s41398-018-0266-8
Mullier E, Roine T, Griffa A, Xin L, Baumann PS, Klauser P, Cleusix M, Jenni R, Alemàn-Gómez Y, Gruetter R, Conus P, Do KQ, Hagmann P (2019) N-acetyl-cysteine supplementation improves functional connectivity within the cingulate cortex in early psychosis: a pilot study. Int J Neuropsychopharmacol 22(8):478–487. https://doi.org/10.1093/ijnp/pyz022
Berk M, Turner A, Malhi GS, Ng CH, Cotton SM, Dodd S, Samuni Y, Tanious M, McAulay C, Dowling N, Sarris J, Owen L, Waterdrinker A, Smith D, Dean OM (2019) A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. BMC Med 17(1):18. https://doi.org/10.1186/s12916-019-1257-1
Forester BP, Harper DG, Georgakas J, Ravichandran C, Madurai N, Cohen BM (2015) Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression. J Clin Psychopharmacol 35(3):338–340. https://doi.org/10.1097/JCP.0000000000000326
Mehrpooya M, Yasrebifar F, Haghighi M, Mohammadi Y, Jahangard L (2018) Evaluating the effect of coenzyme Q10 augmentation on treatment of bipolar depression: a double-blind controlled clinical trial. J Clin Psychopharmacol 38(5):460–466. https://doi.org/10.1097/jcp.0000000000000938
Maguire A, Hargreaves A, Gill M (2018) Coenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia. Nutr Neurosci. https://doi.org/10.1080/1028415x.2018.1556481
Morris G, Anderson G, Berk M, Maes M (2013) Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications. Mol Neurobiol 48(3):883–903. https://doi.org/10.1007/s12035-013-8477-8
Gerwyn M, Maes M (2017) Mechanisms explaining muscle fatigue and muscle pain in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a review of recent findings. Curr Rheumatol Rep 19(1):1. https://doi.org/10.1007/s11926-017-0628-x
Ezerina D, Takano Y, Hanaoka K, Urano Y, Dick TP (2018) N-acetyl cysteine functions as a fast-acting antioxidant by triggering intracellular H2S and sulfane sulfur production. Cell Chem Biol 25(4):447–459.e444. https://doi.org/10.1016/j.chembiol.2018.01.011
Zuhra K, Tome CS, Masi L, Giardina G, Paulini G, Malagrino F, Forte E, Vicente JB, Giuffre A (2019) N-acetylcysteine serves as substrate of 3-mercaptopyruvate sulfurtransferase and stimulates sulfide metabolism in colon cancer cells. Cells. https://doi.org/10.3390/cells8080828
Lambeth JD, Neish AS (2014) Nox enzymes and new thinking on reactive oxygen: a double-edged sword revisited. Annu Rev Pathol 9:119–145. https://doi.org/10.1146/annurev-pathol-012513-104651
Ma MW, Wang J, Dhandapani KM, Brann DW (2017) NADPH oxidase 2 regulates NLRP3 inflammasome activation in the brain after traumatic brain injury. Oxid Med Cell Longev 2017:18. https://doi.org/10.1155/2017/6057609
Angelova PR, Abramov AY (2018) Role of mitochondrial ROS in the brain: from physiology to neurodegeneration. FEBS Lett 592(5):692–702. https://doi.org/10.1002/1873-3468.12964
Miller EW, Tulyathan O, Isacoff EY, Chang CJ (2007) Molecular imaging of hydrogen peroxide produced for cell signaling. Nat Chem Biol 3(5):263–267. https://doi.org/10.1038/nchembio871
Groeger G, Quiney C, Cotter TG (2009) Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal 11(11):2655–2671. https://doi.org/10.1089/ars.2009.2728
Woolley JF, Corcoran A, Groeger G, Landry WD, Cotter TG (2013) Redox-regulated growth factor survival signaling. Antioxid Redox Signal 19(15):1815–1827. https://doi.org/10.1089/ars.2012.5028
Bao L, Avshalumov MV, Rice ME (2005) Partial mitochondrial inhibition causes striatal dopamine release suppression and medium spiny neuron depolarization via H2O2 elevation, not ATP depletion. J Neurosci 25(43):10029–10040. https://doi.org/10.1523/jneurosci.2652-05.2005
Rice ME (2011) H2O2: a dynamic neuromodulator. Neuroscientist 17(4):389–406. https://doi.org/10.1177/1073858411404531
Dantzler HA, Matott MP, Martinez D, Kline DD (2019) Hydrogen peroxide inhibits neurons in the paraventricular nucleus of the hypothalamus via potassium channel activation. Am J Physiol Regul Integr Comp Physiol 317(1):R121–r133. https://doi.org/10.1152/ajpregu.00054.2019
Lee CR, Patel JC, O'Neill B, Rice ME (2015) Inhibitory and excitatory neuromodulation by hydrogen peroxide: translating energetics to information. J Physiol 593(16):3431–3446. https://doi.org/10.1113/jphysiol.2014.273839
Guo C, Sun L, Chen X, Zhang D (2013) Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regeneration Res 8(21):2003–2014. https://doi.org/10.3969/j.issn.1673-5374.2013.21.009
Kausar S, Wang F, Cui H (2018) The role of mitochondria in reactive oxygen species generation and its implications for neurodegenerative diseases. Cells 7(12):274. https://doi.org/10.3390/cells7120274
Morris G, Berk M, Carvalho AF, Maes M, Walker AJ, Puri BK (2018) Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases. Behav Brain Res 341:154–175. https://doi.org/10.1016/j.bbr.2017.12.036
Morris G, Berk M (2015) The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med 13(1):68. https://doi.org/10.1186/s12916-015-0310-y
Cuperfain AB, Zhang ZL, Kennedy JL, Gonçalves VF (2018) The complex interaction of mitochondrial genetics and mitochondrial pathways in psychiatric disease. Mol Neuropsychiatry 4(1):52–69. https://doi.org/10.1159/000488031
Kakkar P, Singh BK (2007) Mitochondria: a hub of redox activities and cellular distress control. Mol Cell Biochem 305(1–2):235–253. https://doi.org/10.1007/s11010-007-9520-8
Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552(Pt 2):335–344. https://doi.org/10.1113/jphysiol.2003.049478
Morris G, Maes M (2014) Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). Curr Neuropharmacol 12(2):168–185. https://doi.org/10.2174/1570159x11666131120224653
Lucas K, Morris G, Anderson G, Maes M (2015) The toll-like receptor radical cycle pathway: a new drug target in immune-related chronic fatigue. CNS Neurol Disorders 14(7):838–854
Pope S, Land JM, Heales SJ (2008) Oxidative stress and mitochondrial dysfunction in neurodegeneration; cardiolipin a critical target? Biochim Biophys Acta 1777(7–8):794–799. https://doi.org/10.1016/j.bbabio.2008.03.011
Paradies G, Petrosillo G, Paradies V, Ruggiero FM (2011) Mitochondrial dysfunction in brain aging: role of oxidative stress and cardiolipin. Neurochem Int 58(4):447–457. https://doi.org/10.1016/j.neuint.2010.12.016
Saki M, Prakash A (2017) DNA damage related crosstalk between the nucleus and mitochondria. Free Radic Biol Med 107:216–227. https://doi.org/10.1016/j.freeradbiomed.2016.11.050
Dikalov S (2011) Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med 51(7):1289–1301. https://doi.org/10.1016/j.freeradbiomed.2011.06.033
Daiber A, Di Lisa F, Oelze M, Kroller-Schon S, Steven S, Schulz E, Munzel T (2017) Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function. Br J Pharmacol 174(12):1670–1689. https://doi.org/10.1111/bph.13403
Kroller-Schon S, Steven S, Kossmann S, Scholz A, Daub S, Oelze M, Xia N, Hausding M, Mikhed Y, Zinssius E, Mader M, Stamm P, Treiber N, Scharffetter-Kochanek K, Li H, Schulz E, Wenzel P, Munzel T, Daiber A (2014) Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models. Antioxid Redox Signal 20(2):247–266. https://doi.org/10.1089/ars.2012.4953
Fransen M, Lismont C, Walton P (2017) The peroxisome-mitochondria connection: how and why? Int J Mol Sci. https://doi.org/10.3390/ijms18061126
Lismont C, Nordgren M, Van Veldhoven PP, Fransen M (2015) Redox interplay between mitochondria and peroxisomes. Front Cell Dev Biol 3:35–35. https://doi.org/10.3389/fcell.2015.00035
Schulz E, Wenzel P, Munzel T, Daiber A (2014) Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid Redox Signal 20(2):308–324. https://doi.org/10.1089/ars.2012.4609
Morris G, Walker AJ, Berk M, Maes M, Puri BK (2018) Cell death pathways: a novel therapeutic approach for neuroscientists. Mol Neurobiol 55(7):5767–5786. https://doi.org/10.1007/s12035-017-0793-y
Galley HF (2011) Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 107(1):57–64. https://doi.org/10.1093/bja/aer093
Litvinova L, Atochin DN, Fattakhov N, Vasilenko M, Zatolokin P, Kirienkova E (2015) Nitric oxide and mitochondria in metabolic syndrome. Front Physiol. https://doi.org/10.3389/fphys.2015.00020
Ghafourifar P, Cadenas E (2005) Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 26(4):190–195. https://doi.org/10.1016/j.tips.2005.02.005
Morris G, Berk M, Klein H, Walder K, Galecki P, Maes M (2017) Nitrosative stress, hypernitrosylation, and autoimmune responses to nitrosylated proteins: new pathways in neuroprogressive disorders including depression and chronic fatigue syndrome. Mol Neurobiol 54(6):4271–4291. https://doi.org/10.1007/s12035-016-9975-2
Lopert P, Patel M (2014) Nicotinamide nucleotide transhydrogenase (Nnt) links the substrate requirement in brain mitochondria for hydrogen peroxide removal to the thioredoxin/peroxiredoxin (Trx/Prx) system. J Biol Chem 289(22):15611–15620. https://doi.org/10.1074/jbc.M113.533653
Drechsel DA, Patel M (2010) Respiration-dependent H2O2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system. J Biol Chem 285(36):27850–27858. https://doi.org/10.1074/jbc.M110.101196
Treberg JR, Braun K, Selseleh P (2019) Mitochondria can act as energy-sensing regulators of hydrogen peroxide availability. Redox Biol 20:483–488. https://doi.org/10.1016/j.redox.2018.11.002
Silva-Adaya D, Gonsebatt M, Guevara J (2014) Thioredoxin system regulation in the central nervous system: experimental models and clinical evidence. Oxid Med Cell Longev 2014:13. https://doi.org/10.1155/2014/590808
Holzerova E, Danhauser K, Haack TB, Kremer LS, Melcher M, Ingold I, Kobayashi S, Terrile C, Wolf P, Schaper J, Mayatepek E, Baertling F, Friedmann Angeli JP, Conrad M, Strom TM, Meitinger T, Prokisch H, Distelmaier F (2016) Human thioredoxin 2 deficiency impairs mitochondrial redox homeostasis and causes early-onset neurodegeneration. Brain 139(Pt 2):346–354. https://doi.org/10.1093/brain/awv350
Cunniff B, Wozniak AN, Sweeney P, DeCosta K, Heintz NH (2014) Peroxiredoxin 3 levels regulate a mitochondrial redox setpoint in malignant mesothelioma cells. Redox Biol 3:79–87. https://doi.org/10.1016/j.redox.2014.11.003
Hanschmann E-M, Godoy JR, Berndt C, Hudemann C, Lillig CH (2013) Thioredoxins, glutaredoxins, and peroxiredoxins–molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal 19(13):1539–1605. https://doi.org/10.1089/ars.2012.4599
Brigelius-Flohe R, Maiorino M (2013) Glutathione peroxidases. Biochim Biophys Acta 1830(5):3289–3303. https://doi.org/10.1016/j.bbagen.2012.11.020
Couto N, Wood J, Barber J (2016) The role of glutathione reductase and related enzymes on cellular redox homoeostasis network. Free Radic Biol Med 95:27–42. https://doi.org/10.1016/j.freeradbiomed.2016.02.028
Kalinina EV, Chernov NN, Saprin AN (2008) Involvement of thio-, peroxi-, and glutaredoxins in cellular redox-dependent processes. Biochem Biokhimiia 73(13):1493–1510
Sugadev R, Ponnuswamy MN, Sekar K (2011) Structural analysis of NADPH depleted bovine liver catalase and its inhibitor complexes. Int J Biochem Mol Biol 2(1):67–77
Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M, Maes M (2014) The glutathione system: a new drug target in neuroimmune disorders. Mol Neurobiol 50(3):1059–1084. https://doi.org/10.1007/s12035-014-8705-x
Mari M, Morales A, Colell A, Garcia-Ruiz C, Fernandez-Checa JC (2009) Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11(11):2685–2700. https://doi.org/10.1089/ars.2009.2695
Maroz A, Anderson RF, Smith RA, Murphy MP (2009) Reactivity of ubiquinone and ubiquinol with superoxide and the hydroperoxyl radical: implications for in vivo antioxidant activity. Free Radic Biol Med 46(1):105–109. https://doi.org/10.1016/j.freeradbiomed.2008.09.033
Kc S, Carcamo JM, Golde DW (2005) Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J 19(12):1657–1667. https://doi.org/10.1096/fj.05-4107com
Lauridsen C, Jensen SK (2012) alpha-Tocopherol incorporation in mitochondria and microsomes upon supranutritional vitamin E supplementation. Genes Nutr 7(4):475–482. https://doi.org/10.1007/s12263-012-0286-6
Ekoue DN, He C, Diamond AM (1858) Manganese superoxide dismutase and glutathione peroxidase-1 contribute to the rise and fall of mitochondrial reactive oxygen species which drive oncogenesis. Biochim Biophys Acta 8:628–632. https://doi.org/10.1016/j.bbabio.2017.01.006
Handy DE, Lubos E, Yang Y, Galbraith JD, Kelly N, Zhang Y-Y, Leopold JA, Loscalzo J (2009) Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses. J Biol Chem 284(18):11913–11921. https://doi.org/10.1074/jbc.M900392200
De Simoni S, Linard D, Hermans E, Knoops B, Goemaere J (2013) Mitochondrial peroxiredoxin-5 as potential modulator of mitochondria-ER crosstalk in MPP+-induced cell death. J Neurochem 125(3):473–485. https://doi.org/10.1111/jnc.12117
De Simoni S, Goemaere J, Knoops B (2008) Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+. Neurosci Lett 433(3):219–224. https://doi.org/10.1016/j.neulet.2007.12.068
Sun C-C, Dong W-R, Shao T, Li J-Y, Zhao J, Nie L, Xiang L-X, Zhu G, Shao J-Z (2017) Peroxiredoxin 1 (Prx1) is a dual-function enzyme by possessing Cys-independent catalase-like activity. Biochem J 474(8):1373–1394. https://doi.org/10.1042/bcj20160851
Peskin AV, Dickerhof N, Poynton RA, Paton LN, Pace PE, Hampton MB, Winterbourn CC (2013) Hyperoxidation of peroxiredoxins 2 and 3: rate constants for the reactions of the sulfenic acid of the peroxidatic cysteine. J Biol Chem 288(20):14170–14177. https://doi.org/10.1074/jbc.M113.460881
Stanley BA, Sivakumaran V, Shi S, McDonald I, Lloyd D, Watson WH, Aon MA, Paolocci N (2011) Thioredoxin reductase-2 is essential for keeping low levels of H2O2 emission from isolated heart mitochondria. J Biol Chem 286(38):33669–33677. https://doi.org/10.1074/jbc.M111.284612
Mailloux RJ (2018) Mitochondrial antioxidants and the maintenance of cellular hydrogen peroxide levels. Oxid Med Cell Longev 2018:7857251–7857251. https://doi.org/10.1155/2018/7857251
Saccoccia F, Angelucci F, Boumis G, Carotti D, Desiato G, Miele AE, Bellelli A (2014) Thioredoxin reductase and its inhibitors. Curr Protein Pept Sci 15(6):621–646
Noh YH, Baek JY, Jeong W, Rhee SG, Chang TS (2009) Sulfiredoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J Biol Chem 284(13):8470–8477. https://doi.org/10.1074/jbc.M808981200
Jeong EA, Jeon BT, Shin HJ, Kim N, Lee DH, Kim HJ, Kang SS, Cho GJ, Choi WS, Roh GS (2011) Ketogenic diet-induced peroxisome proliferator-activated receptor-gamma activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures. Exp Neurol 232(2):195–202. https://doi.org/10.1016/j.expneurol.2011.09.001
Adimora NJ, Jones DP, Kemp ML (2010) A model of redox kinetics implicates the thiol proteome in cellular hydrogen peroxide responses. Antioxid Redox Signal 13(6):731–743. https://doi.org/10.1089/ars.2009.2968
Rhee SG, Woo HA (2011) Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H(2)O(2), and protein chaperones. Antioxid Redox Signal 15(3):781–794. https://doi.org/10.1089/ars.2010.3393
Rhee SG (2016) Overview on peroxiredoxin. Mol Cells 39(1):1–5. https://doi.org/10.14348/molcells.2016.2368
Jeong W, Bae SH, Toledano MB, Rhee SG (2012) Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression. Free Radic Biol Med 53(3):447–456. https://doi.org/10.1016/j.freeradbiomed.2012.05.020
Baek JY, Han SH, Sung SH, Lee HE, Kim YM, Noh YH, Bae SH, Rhee SG, Chang TS (2012) Sulfiredoxin protein is critical for redox balance and survival of cells exposed to low steady-state levels of H2O2. J Biol Chem 287(1):81–89. https://doi.org/10.1074/jbc.M111.316711
Lopert P, Day BJ, Patel M (2012) Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells. PLoS ONE 7(11):e50683. https://doi.org/10.1371/journal.pone.0050683
Kudin AP, Augustynek B, Lehmann AK, Kovács R (1817) Kunz WS (2012) The contribution of thioredoxin-2 reductase and glutathione peroxidase to H2O2 detoxification of rat brain mitochondria. Biochimica et Biophysica Acta (BBA) 10:1901–1906. https://doi.org/10.1016/j.bbabio.2012.02.023
Fisher-Wellman KH, Gilliam LAA, Lin CT, Cathey BL, Lark DS, Darrell Neufer P (2013) Mitochondrial glutathione depletion reveals a novel role for the pyruvate dehydrogenase complex as a key H2O2-emitting source under conditions of nutrient overload. Free Radic Biol Med 65:1201–1208. https://doi.org/10.1016/j.freeradbiomed.2013.09.008
Munro D, Banh S, Sotiri E, Tamanna N, Treberg JR (2016) The thioredoxin and glutathione-dependent H2O2 consumption pathways in muscle mitochondria: Involvement in H2O2 metabolism and consequence to H2O2 efflux assays. Free Radic Biol Med 96:334–346. https://doi.org/10.1016/j.freeradbiomed.2016.04.014
Starkov AA, Andreyev AY, Zhang SF, Starkova NN, Korneeva M, Syromyatnikov M, Popov VN (2014) Scavenging of H2O2 by mouse brain mitochondria. J Bioenerg Biomembr 46(6):471–477. https://doi.org/10.1007/s10863-014-9581-9
Hamilton RT, Walsh ME, Van Remmen H (2012) Mouse models of oxidative stress indicate a role for modulating healthy aging. J Clin Exp Pathol. https://doi.org/10.4172/2161-0681.s4-005
Cox AG, Winterbourn CC, Hampton MB (2009) Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J 425(2):313–325. https://doi.org/10.1042/bj20091541
Gray E, Kemp K, Hares K, Redondo J, Rice C, Scolding N, Wilkins A (2014) Increased microglial catalase activity in multiple sclerosis grey matter. Brain Res 1559:55–64. https://doi.org/10.1016/j.brainres.2014.02.042
Rohrdanz E, Schmuck G, Ohler S, Kahl R (2001) The influence of oxidative stress on catalase and MnSOD gene transcription in astrocytes. Brain Res 900(1):128–136. https://doi.org/10.1016/s0006-8993(01)02277-6
Ho YS, Xiong Y, Ma W, Spector A, Ho DS (2004) Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 279(31):32804–32812. https://doi.org/10.1074/jbc.M404800200
Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, Freeman BA (1991) Detection of catalase in rat heart mitochondria. J Biol Chem 266(32):22028–22034
Salvi M, Battaglia V, Brunati AM, La Rocca N, Tibaldi E, Pietrangeli P, Marcocci L, Mondovì B, Rossi CA, Toninello A (2007) Catalase takes part in rat liver mitochondria oxidative stress defense. J Biol Chem 282(33):24407–24415. https://doi.org/10.1074/jbc.M701589200
Munro D, Treberg JR (2017) A radical shift in perspective: mitochondria as regulators of reactive oxygen species. J Exp Biol 220(7):1170–1180. https://doi.org/10.1242/jeb.132142
Dey S, Sidor A, O'Rourke B (2016) Compartment-specific control of reactive oxygen species scavenging by antioxidant pathway enzymes. J Biol Chem 291(21):11185–11197. https://doi.org/10.1074/jbc.M116.726968
Ronchi JA, Francisco A, Passos LA, Figueira TR, Castilho RF (2016) The contribution of nicotinamide nucleotide transhydrogenase to peroxide detoxification is dependent on the respiratory state and counterbalanced by other sources of NADPH in liver mitochondria. J Biol Chem 291(38):20173–20187. https://doi.org/10.1074/jbc.M116.730473
Santos LRB, Muller C, de Souza AH, Takahashi HK, Spegel P, Sweet IR, Chae H, Mulder H, Jonas JC (2017) NNT reverse mode of operation mediates glucose control of mitochondrial NADPH and glutathione redox state in mouse pancreatic beta-cells. Mol Metab 6(6):535–547. https://doi.org/10.1016/j.molmet.2017.04.004
Rydstrom J (2006) Mitochondrial NADPH, transhydrogenase and disease. Biochim Biophys Acta 1757(5–6):721–726. https://doi.org/10.1016/j.bbabio.2006.03.010
Montano SJ, Lu J, Gustafsson TN, Holmgren A (2014) Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples. Anal Biochem 449:139–146. https://doi.org/10.1016/j.ab.2013.12.025
Cheng Q, Antholine WE, Myers JM, Kalyanaraman B, Arner ES, Myers CR (2010) The selenium-independent inherent pro-oxidant NADPH oxidase activity of mammalian thioredoxin reductase and its selenium-dependent direct peroxidase activities. J Biol Chem 285(28):21708–21723. https://doi.org/10.1074/jbc.M110.117259
Berkholz DS, Faber HR, Savvides SN, Karplus PA (2008) Catalytic cycle of human glutathione reductase near 1 A resolution. J Mol Biol 382(2):371–384. https://doi.org/10.1016/j.jmb.2008.06.083
Kamerbeek NM, van Zwieten R, de Boer M, Morren G, Vuil H, Bannink N, Lincke C, Dolman KM, Becker K, Heiner Schirmer R, Gromer S, Roos D (2007) Molecular basis of glutathione reductase deficiency in human blood cells. Blood 109(8):3560–3566. https://doi.org/10.1182/blood-2006-08-042531
Linster CL, Van Schaftingen E (2007) Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J 274(1):1–22. https://doi.org/10.1111/j.1742-4658.2006.05607.x
Bradshaw PC (2019) Cytoplasmic and mitochondrial NADPH-coupled redox systems in the regulation of aging. Nutrients 11(3):504. https://doi.org/10.3390/nu11030504
Arroyo A, Kagan VE, Tyurin VA, Burgess JR, de Cabo R, Navas P, Villalba JM (2000) NADH and NADPH-dependent reduction of coenzyme Q at the plasma membrane. Antioxid Redox Signal 2(2):251–262. https://doi.org/10.1089/ars.2000.2.2-251
Takahashi T, Okuno M, Okamoto T, Kishi T (2008) NADPH-dependent coenzyme Q reductase is the main enzyme responsible for the reduction of non-mitochondrial CoQ in cells. BioFactors (Oxford, England) 32(1–4):59–70
Heck DE, Shakarjian M, Kim HD, Laskin JD, Vetrano AM (2010) Mechanisms of oxidant generation by catalase. Ann N Y Acad Sci 1203:120–125. https://doi.org/10.1111/j.1749-6632.2010.05603.x
Holper L, Ben-Shachar D, Mann JJ (2019) Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease. Neuropsychopharmacology 44(5):837–849. https://doi.org/10.1038/s41386-018-0090-0
Kim Y, Vadodaria KC, Lenkei Z, Kato T, Gage FH, Marchetto MC, Santos R (2019) Mitochondria, metabolism, and redox mechanisms in psychiatric disorders. Antioxid Redox Signal 31(4):275–317. https://doi.org/10.1089/ars.2018.7606
Fang J, Holmgren A (2006) Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J Am Chem Soc 128(6):1879–1885. https://doi.org/10.1021/ja057358l
Cruz-Tapias P, Agmon-Levin N, Israeli E, Anaya JM, Shoenfeld Y (2013) Autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA)–animal models as a proof of concept. Curr Med Chem 20(32):4030–4036
Garcia-Nogales P, Almeida A, Bolanos JP (2003) Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection. J Biol Chem 278(2):864–874. https://doi.org/10.1074/jbc.M206835200
Bayir H, Kagan VE, Clark RS, Janesko-Feldman K, Rafikov R, Huang Z, Zhang X, Vagni V, Billiar TR, Kochanek PM (2007) Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J Neurochem 101(1):168–181. https://doi.org/10.1111/j.1471-4159.2006.04353.x
Isobe C, Abe T, Terayama Y (2009) Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer’s disease patients. Dement Geriatr Cogn Disord 28(5):434–439. https://doi.org/10.1159/000256209
Gomez-Diaz C, Rodriguez-Aguilera JC, Barroso MP, Villalba JM, Navarro F, Crane FL, Navas P (1997) Antioxidant ascorbate is stabilized by NADH-coenzyme Q10 reductase in the plasma membrane. J Bioenergy Biomembr 29(3):251–257
Bello RI, Kagan VE, Tyurin V, Navarro F, Alcain FJ, Villalba JM (2003) Regeneration of lipophilic antioxidants by NAD(P)H:quinone oxidoreductase 1. Protoplasma 221(1–2):129–135. https://doi.org/10.1007/s00709-002-0068-x
Liu Q, Gao Y, Ci X (2019) Role of Nrf2 and its activators in respiratory diseases. Oxid Med Cell Longev 2019:17. https://doi.org/10.1155/2019/7090534
Wu YT, Wu SB, Lee WY, Wei YH (2010) Mitochondrial respiratory dysfunction-elicited oxidative stress and posttranslational protein modification in mitochondrial diseases. Ann N Y Acad Sci 1201:147–156. https://doi.org/10.1111/j.1749-6632.2010.05631.x
Wang CH, Wu SB, Wu YT, Wei YH (2013) Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp Biol Med (Maywood, NJ) 238(5):450–460. https://doi.org/10.1177/1535370213493069
Ashrafi G, Schlehe JS, LaVoie MJ, Schwarz TL (2014) Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J Cell Biol 206(5):655–670. https://doi.org/10.1083/jcb.201401070
Kubli DA, Gustafsson ÅB (2012) Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 111(9):1208–1221. https://doi.org/10.1161/CIRCRESAHA.112.265819
Zhang Q, Padayatti PS, Leung JH (2017) Proton-translocating nicotinamide nucleotide transhydrogenase: a structural perspective. Front Physiol 8:1089. https://doi.org/10.3389/fphys.2017.01089
Padayatti PS, Leung JH, Mahinthichaichan P, Tajkhorshid E, Ishchenko A, Cherezov V, Soltis SM, Jackson JB, Stout CD, Gennis RB, Zhang Q (2017) Critical role of water molecules in proton translocation by the membrane-bound transhydrogenase. Structure 25(7):1111–1119.e1113. https://doi.org/10.1016/j.str.2017.05.022
Leung JH, Schurig-Briccio LA, Yamaguchi M, Moeller A, Speir JA, Gennis RB, Stout CD (2015) Structural biology. Division of labor in transhydrogenase by alternating proton translocation and hydride transfer. Science 347(6218):178–181. https://doi.org/10.1126/science.1260451
Ho H-Y, Lin Y-T, Lin G, Wu P-R, Cheng M-L (2017) Nicotinamide nucleotide transhydrogenase (NNT) deficiency dysregulates mitochondrial retrograde signaling and impedes proliferation. Redox Biol 12:916–928. https://doi.org/10.1016/j.redox.2017.04.035
Murphy Michael P (2015) Redox modulation by reversal of the mitochondrial nicotinamide nucleotide transhydrogenase. Cell Metab 22(3):363–365. https://doi.org/10.1016/j.cmet.2015.08.012
Ronchi JA, Figueira TR, Ravagnani FG, Oliveira HC, Vercesi AE, Castilho RF (2013) A spontaneous mutation in the nicotinamide nucleotide transhydrogenase gene of C57BL/6J mice results in mitochondrial redox abnormalities. Free Radic Biol Med 63:446–456. https://doi.org/10.1016/j.freeradbiomed.2013.05.049
Yin F, Sancheti H (1817) Cadenas E (2012) Silencing of nicotinamide nucleotide transhydrogenase impairs cellular redox homeostasis and energy metabolism in PC12 cells. Biochim Biophys Acta 3:401–409. https://doi.org/10.1016/j.bbabio.2011.12.004
Sheeran FL, Rydström J, Shakhparonov MI, Pestov NB, Pepe S (2010) Diminished NADPH transhydrogenase activity and mitochondrial redox regulation in human failing myocardium. Biochimica et Biophysica Acta (BBA) 1797(6):1138–1148. https://doi.org/10.1016/j.bbabio.2010.04.002
Francisco A, Ronchi JA, Navarro CDC, Figueira TR, Castilho RF (2018) Nicotinamide nucleotide transhydrogenase is required for brain mitochondrial redox balance under hampered energy substrate metabolism and high-fat diet. J Neurochem 147(5):663–677. https://doi.org/10.1111/jnc.14602
Navarro CDC, Figueira TR, Francisco A, Dal'Bo GA, Ronchi JA, Rovani JC, Escanhoela CAF, Oliveira HCF, Castilho RF, Vercesi AE (2017) Redox imbalance due to the loss of mitochondrial NAD(P)-transhydrogenase markedly aggravates high fat diet-induced fatty liver disease in mice. Free Radic Biol Med 113:190–202. https://doi.org/10.1016/j.freeradbiomed.2017.09.026
Nickel Alexander G, von Hardenberg A, Hohl M, Löffler Joachim R, Kohlhaas M, Becker J, Reil J-C, Kazakov A, Bonnekoh J, Stadelmaier M, Puhl S-L, Wagner M, Bogeski I, Cortassa S, Kappl R, Pasieka B, Lafontaine M, Lancaster C, Roy D, Blacker Thomas S, Hall Andrew R, Duchen Michael R, Kästner L, Lipp P, Zeller T, Müller C, Knopp A, Laufs U, Böhm M, Hoth M, Maack C (2015) Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure. Cell Metab 22(3):472–484. https://doi.org/10.1016/j.cmet.2015.07.008
Chortis V, Taylor AE, Doig CL, Walsh MD, Meimaridou E, Jenkinson C, Rodriguez-Blanco G, Ronchi CL, Jafri A, Metherell LA, Hebenstreit D, Dunn WB, Arlt W, Foster PA (2018) Nicotinamide nucleotide transhydrogenase as a novel treatment target in adrenocortical carcinoma. Endocrinology 159(8):2836–2849. https://doi.org/10.1210/en.2018-00014
Zhang R (2015) MNADK, a long-awaited human mitochondrion-localized NAD kinase. J Cell Physiol 230(8):1697–1701. https://doi.org/10.1002/jcp.24926
Ohashi K, Kawai S, Murata K (2012) Identification and characterization of a human mitochondrial NAD kinase. Nat Commun 3:1248. https://doi.org/10.1038/ncomms2262
Love NR, Pollak N, Dölle C, Niere M, Chen Y, Oliveri P, Amaya E, Patel S, Ziegler M (2015) NAD kinase controls animal NADP biosynthesis and is modulated via evolutionarily divergent calmodulin-dependent mechanisms. Proc Natl Acad Sci USA 112(5):1386–1391. https://doi.org/10.1073/pnas.1417290112
Hoxhaj G, Ben-Sahra I, Lockwood SE, Timson RC, Byles V, Henning GT, Gao P, Selfors LM, Asara JM, Manning BD (2019) Direct stimulation of NADP+ synthesis through Akt-mediated phosphorylation of NAD kinase. Science 363(6431):1088–1092. https://doi.org/10.1126/science.aau3903
Pollak N, Niere M, Ziegler M (2007) NAD kinase levels control the NADPH concentration in human cells. J Biol Chem 282(46):33562–33571. https://doi.org/10.1074/jbc.M704442200
Houten SM, Denis S, Te Brinke H, Jongejan A, van Kampen AH, Bradley EJ, Baas F, Hennekam RC, Millington DS, Young SP, Frazier DM, Gucsavas-Calikoglu M, Wanders RJ (2014) Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. Hum Mol Genet 23(18):5009–5016. https://doi.org/10.1093/hmg/ddu218
Tort F, Ugarteburu O, Torres MA, Garcia-Villoria J, Giros M, Ruiz A, Ribes A (2016) Lysine restriction and pyridoxal phosphate administration in a NADK2 patient. Pediatrics. https://doi.org/10.1542/peds.2015-4534
Kawai S, Murata K (2008) Structure and function of NAD kinase and NADP phosphatase: key enzymes that regulate the intracellular balance of NAD(H) and NADP(H). Biosci Biotechnol Biochem 72(4):919–930. https://doi.org/10.1271/bbb.70738
Magni G, Orsomando G, Raffaelli N (2006) Structural and functional properties of NAD kinase, a key enzyme in NADP biosynthesis. Mini Rev Med Chem 6(7):739–746
Grose JH, Joss L, Velick SF, Roth JR (2006) Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress. Proc Natl Acad Sci USA 103(20):7601–7606. https://doi.org/10.1073/pnas.0602494103
Ohashi K, Kawai S, Koshimizu M, Murata K (2011) NADPH regulates human NAD kinase, a NADP(+)-biosynthetic enzyme. Mol Cell Biochem 355(1–2):57–64. https://doi.org/10.1007/s11010-011-0838-x
Petrelli R, Felczak K, Cappellacci L (2011) NMN/NaMN adenylyltransferase (NMNAT) and NAD kinase (NADK) inhibitors: chemistry and potential therapeutic applications. Curr Med Chem 18(13):1973–1992
Shi F, Li Y, Li Y, Wang X (2009) Molecular properties, functions, and potential applications of NAD kinases. Acta Biochim Biophys Sin 41(5):352–361. https://doi.org/10.1093/abbs/gmp029
Revollo JR, Grimm AA, Imai S-I (2004) The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279(49):50754–50763. https://doi.org/10.1074/jbc.M408388200
Jayaram HN, Kusumanchi P, Yalowitz JA (2011) NMNAT expression and its relation to NAD metabolism. Curr Med Chem 18(13):1962–1972. https://doi.org/10.2174/092986711795590138
Pittelli M, Formentini L, Faraco G, Lapucci A, Rapizzi E, Cialdai F, Romano G, Moneti G, Moroni F, Chiarugi A (2010) Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool. J Biol Chem 285(44):34106–34114. https://doi.org/10.1074/jbc.M110.136739
Burgos ES (2011) NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism. Curr Med Chem 18(13):1947–1961. https://doi.org/10.2174/092986711795590101
Burgos ES, Schramm VL (2008) Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase. Biochemistry 47(42):11086–11096. https://doi.org/10.1021/bi801198m
Zhang LQ, Van Haandel L, Xiong M, Huang P, Heruth DP, Bi C, Gaedigk R, Jiang X, Li D-Y, Wyckoff G, Grigoryev DN, Gao L, Li L, Wu M, Leeder JS, Ye SQ (2017) Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase. Cell Death Dis 8:e2705. https://doi.org/10.1038/cddis.2017.132
Zhang LQ, Heruth DP, Ye SQ (2011) Nicotinamide phosphoribosyltransferase in human diseases. J Bioanal Biomed 3:13–25. https://doi.org/10.4172/1948-593X.1000038
Abeti R, Duchen MR (2012) Activation of PARP by oxidative stress induced by beta-amyloid: implications for Alzheimer's disease. Neurochem Res 37(11):2589–2596. https://doi.org/10.1007/s11064-012-0895-x
Smith AJ, Ball SS, Bowater RP, Wormstone IM (2016) PARP-1 inhibition influences the oxidative stress response of the human lens. Redox Biol 8:354–362. https://doi.org/10.1016/j.redox.2016.03.003
Rodriguez-Vargas JM, Ruiz-Magana MJ, Ruiz-Ruiz C, Majuelos-Melguizo J, Peralta-Leal A, Rodriguez MI, Munoz-Gamez JA, de Almodovar MR, Siles E, Rivas AL, Jaattela M, Oliver FJ (2012) ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy. Cell Res 22(7):1181–1198. https://doi.org/10.1038/cr.2012.70
Alano CC, Garnier P, Ying W, Higashi Y, Kauppinen TM, Swanson RA (2010) NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. J Neurosci 30(8):2967–2978. https://doi.org/10.1523/JNEUROSCI.5552-09.2010
Imai S-I (2009) Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr Pharm Des 15(1):20–28. https://doi.org/10.2174/138161209787185814
Zhang D, Hu X, Li J, Liu J, Baks-Te Bulte L, Wiersma M, Malik NU, van Marion DMS, Tolouee M, Hoogstra-Berends F, Lanters EAH, van Roon AM, de Vries AAF, Pijnappels DA, de Groot NMS, Henning RH, Brundel B (2019) DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD(+) depletion in experimental atrial fibrillation. Nat Commun 10(1):1307. https://doi.org/10.1038/s41467-019-09014-2
Stein LR, Imai S-I (2012) The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab 23(9):420–428. https://doi.org/10.1016/j.tem.2012.06.005
Hopp A-K, Grüter P, Hottiger MO (2019) Regulation of Glucose Metabolism by NAD(+) and ADP-Ribosylation. Cells 8(8):890. https://doi.org/10.3390/cells8080890
Lewis CA, Parker SJ, Fiske BP, McCloskey D, Gui DY, Green CR, Vokes NI, Feist AM, Vander Heiden MG, Metallo CM (2014) Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol Cell 55(2):253–263. https://doi.org/10.1016/j.molcel.2014.05.008
Hsieh J-Y, Shih W-T, Kuo Y-H, Liu G-Y, Hung H-C (2019) Functional roles of metabolic intermediates in regulating the human mitochondrial NAD(P)+-dependent malic enzyme. Sci Rep 9(1):9081. https://doi.org/10.1038/s41598-019-45282-0
Yamada S, Kotake Y, Demizu Y, Kurihara M, Sekino Y, Kanda Y (2014) NAD-dependent isocitrate dehydrogenase as a novel target of tributyltin in human embryonic carcinoma cells. Sci Rep 4:5952–5952. https://doi.org/10.1038/srep05952
Tsybovsky Y, Malakhau Y, Strickland KC, Krupenko SA (2013) The mechanism of discrimination between oxidized and reduced coenzyme in the aldehyde dehydrogenase domain of Aldh1l1. Chem Biol Interact 202(1–3):62–69. https://doi.org/10.1016/j.cbi.2012.12.015
Singh S, Brocker C, Koppaka V, Chen Y, Jackson BC, Matsumoto A, Thompson DC, Vasiliou V (2013) Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. Free Radical Biol Med 56:89–101. https://doi.org/10.1016/j.freeradbiomed.2012.11.010
Shin M, Bryant JD, Momb J, Appling DR (2014) Mitochondrial MTHFD2L is a dual redox cofactor-specific methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase expressed in both adult and embryonic tissues. J Biol Chem 289(22):15507–15517. https://doi.org/10.1074/jbc.M114.555573
Tedeschi PM, Vazquez A, Kerrigan JE, Bertino JR (2015) Mitochondrial methylenetetrahydrofolate dehydrogenase (MTHFD2) overexpression is associated with tumor cell proliferation and is a novel target for drug development. Mol Cancer Res 13(10):1361–1366. https://doi.org/10.1158/1541-7786.mcr-15-0117
Martínez-Reyes I, Chandel NS (2014) Mitochondrial one-carbon metabolism maintains redox balance during hypoxia. Cancer Discov 4(12):1371–1373. https://doi.org/10.1158/2159-8290.CD-14-1228
Zheng Y, Lin TY, Lee G, Paddock MN, Momb J, Cheng Z, Li Q, Fei DL, Stein BD, Ramsamooj S, Zhang G, Blenis J, Cantley LC (2018) Mitochondrial one-carbon pathway supports cytosolic folate integrity in cancer cells. Cell 175(6):1546–1560.e1517. https://doi.org/10.1016/j.cell.2018.09.041
Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB, Rabinowitz JD (2014) Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510(7504):298–302. https://doi.org/10.1038/nature13236
Zeng C, Aleshin AE, Hardie JB, Harrison RW, Fromm HJ (1996) ATP-binding site of human brain hexokinase as studied by molecular modeling and site-directed mutagenesis. Biochemistry 35(40):13157–13164. https://doi.org/10.1021/bi960750e
Wilson JE (2003) Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 206(12):2049–2057. https://doi.org/10.1242/jeb.00241
John S, Weiss JN, Ribalet B (2011) Subcellular localization of hexokinases I and II directs the metabolic fate of glucose. PLoS ONE 6(3):e17674. https://doi.org/10.1371/journal.pone.0017674
Roberts DJ, Miyamoto S (2015) Hexokinase II integrates energy metabolism and cellular protection: akting on mitochondria and TORCing to autophagy. Cell Death Differ 22(2):248–257. https://doi.org/10.1038/cdd.2014.173
Mailloux RJ, Jin X, Willmore WG (2013) Redox regulation of mitochondrial function with emphasis on cysteine oxidation reactions. Redox Biol 2:123–139. https://doi.org/10.1016/j.redox.2013.12.011
Shi Q, Xu H, Kleinman WA, Gibson GE (2008) Novel functions of the α-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease. Biochimica et Biophysica Acta (BBA) 1782(4):229–238. https://doi.org/10.1016/j.bbadis.2007.12.008
Tretter L, Adam-Vizi V (2000) Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J Neurosci 20(24):8972–8979
Hiller S, DeKroon R, Hamlett ED, Xu L, Osorio C, Robinette J, Winnik W, Simington S, Maeda N, Alzate O, Yi X (2016) Alpha-lipoic acid supplementation protects enzymes from damage by nitrosative and oxidative stress. Biochim Biophys Acta 1860:36–45. https://doi.org/10.1016/j.bbagen.2015.09.001
Adam-Vizi V, Tretter L (2013) The role of mitochondrial dehydrogenases in the generation of oxidative stress. Neurochem Int 62(5):757–763. https://doi.org/10.1016/j.neuint.2013.01.012
Wu N, Yang M, Gaur U, Xu H, Yao Y, Li D (2016) Alpha-ketoglutarate: physiological functions and applications. Biomol Ther (Seoul) 24(1):1–8. https://doi.org/10.4062/biomolther.2015.078
Tretter L, Adam-Vizi V (2005) Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. Philos Trans R Soc Lond B Biol Sci 360(1464):2335–2345. https://doi.org/10.1098/rstb.2005.1764
Tortora V, Quijano C, Freeman B, Radi R, Castro L (2007) Mitochondrial aconitase reaction with nitric oxide, S-nitrosoglutathione, and peroxynitrite: mechanisms and relative contributions to aconitase inactivation. Free Radic Biol Med 42(7):1075–1088. https://doi.org/10.1016/j.freeradbiomed.2007.01.007
Han D, Canali R, Garcia J, Aguilera R, Gallaher TK, Cadenas E (2005) Sites and mechanisms of aconitase inactivation by peroxynitrite: modulation by citrate and glutathione. Biochemistry 44(36):11986–11996. https://doi.org/10.1021/bi0509393
Lushchak OV, Piroddi M, Galli F, Lushchak VI (2014) Aconitase post-translational modification as a key in linkage between Krebs cycle, iron homeostasis, redox signaling, and metabolism of reactive oxygen species. Redox Rep 19(1):8–15. https://doi.org/10.1179/1351000213y.0000000073
Hurd TR, Collins Y, Abakumova I, Chouchani ET, Baranowski B, Fearnley IM, Prime TA, Murphy MP, James AM (2012) Inactivation of pyruvate dehydrogenase kinase 2 by mitochondrial reactive oxygen species. J Biol Chem 287(42):35153–35160. https://doi.org/10.1074/jbc.M112.400002
Yang ES, Richter C, Chun JS, Huh TL, Kang SS, Park JW (2002) Inactivation of NADP(+)-dependent isocitrate dehydrogenase by nitric oxide. Free Radic Biol Med 33(7):927–937. https://doi.org/10.1016/s0891-5849(02)00981-4
Lee JH, Yang ES, Park JW (2003) Inactivation of NADP+-dependent isocitrate dehydrogenase by peroxynitrite. Implications for cytotoxicity and alcohol-induced liver injury. J Biol Chem 278(51):51360–51371. https://doi.org/10.1074/jbc.M302332200
Kil IS, Park JW (2005) Regulation of mitochondrial NADP+-dependent isocitrate dehydrogenase activity by glutathionylation. J Biol Chem 280(11):10846–10854. https://doi.org/10.1074/jbc.M411306200
Jiang P, Du W, Mancuso A, Wellen KE, Yang X (2013) Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 493(7434):689–693. https://doi.org/10.1038/nature11776
Chang Y-L, Gao H-W, Chiang C-P, Wang W-M, Huang S-M, Ku C-F, Liu G-Y, Hung H-C (2015) Human mitochondrial NAD(P)+–dependent malic enzyme participates in cutaneous melanoma progression and invasion. J Investig Dermatol 135(3):807–815. https://doi.org/10.1038/jid.2014.385
Reisz JA, Wither MJ, Dzieciatkowska M, Nemkov T, Issaian A, Yoshida T, Dunham AJ, Hill RC, Hansen KC, D'Alessandro A (2016) Oxidative modifications of glyceraldehyde 3-phosphate dehydrogenase regulate metabolic reprogramming of stored red blood cells. Blood 128(12):e32–42. https://doi.org/10.1182/blood-2016-05-714816
Hansen JM, Zhang H, Jones DP (2006) Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions. Free Radical Biol Med 40(1):138–145. https://doi.org/10.1016/j.freeradbiomed.2005.09.023
Pias EK, Ekshyyan OY, Rhoads CA, Fuseler J, Harrison L, Aw TY (2003) Differential effects of superoxide dismutase isoform expression on hydroperoxide-induced apoptosis in PC-12 cells. J Biol Chem 278(15):13294–13301. https://doi.org/10.1074/jbc.M208670200
Francescutti D, Baldwin J, Lee L, Mutus B (1996) Peroxynitrite modification of glutathione reductase: modeling studies and kinetic evidence suggest the modification of tyrosines at the glutathione disulfide binding site. Protein Eng 9(2):189–194
Savvides SN, Scheiwein M, Bohme CC, Arteel GE, Karplus PA, Becker K, Schirmer RH (2002) Crystal structure of the antioxidant enzyme glutathione reductase inactivated by peroxynitrite. J Biol Chem 277(4):2779–2784. https://doi.org/10.1074/jbc.M108190200
Circu ML, Stringer S, Rhoads CA, Moyer MP, Aw TY (2009) The role of GSH efflux in staurosporine-induced apoptosis in colonic epithelial cells. Biochem Pharmacol 77(1):76–85. https://doi.org/10.1016/j.bcp.2008.09.011
Franco R, Cidlowski JA (2012) Glutathione efflux and cell death. Antioxid Redox Signal 17(12):1694–1713. https://doi.org/10.1089/ars.2012.4553
Hammond CL, Madejczyk MS, Ballatori N (2004) Activation of plasma membrane reduced glutathione transport in death receptor apoptosis of HepG2 cells. Toxicol Appl Pharmacol 195(1):12–22. https://doi.org/10.1016/j.taap.2003.10.008
Sodani K, Patel A, Kathawala RJ, Chen Z-S (2012) Multidrug resistance associated proteins in multidrug resistance. Chin J Cancer 31(2):58–72. https://doi.org/10.5732/cjc.011.10329
Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, Dringen R (2006) The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J Neurochem 97(2):373–384. https://doi.org/10.1111/j.1471-4159.2006.03737.x
Hirrlinger J, Dringen R (2005) Multidrug resistance protein 1-mediated export of glutathione and glutathione disulfide from brain astrocytes. Methods Enzymol 400:395–409. https://doi.org/10.1016/s0076-6879(05)00023-6
Ballatori N, Krance SM, Marchan R, Hammond CL (2009) Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol Aspects Med 30(1–2):13–28. https://doi.org/10.1016/j.mam.2008.08.004
Hashemy SI, Holmgren A (2008) Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem 283(32):21890–21898. https://doi.org/10.1074/jbc.M801047200
Rassaf T, Luedike P (2010) Between nitros(yl)ation and nitration: regulation of thioredoxin-1 in myocardial ischemia/reperfusion injury. J Mol Cell Cardiol 49(3):343–346. https://doi.org/10.1016/j.yjmcc.2010.06.001
Yin T, Hou R, Liu S, Lau WB, Wang H, Tao L (2010) Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury. J Mol Cell Cardiol 49(3):354–361. https://doi.org/10.1016/j.yjmcc.2010.05.002
Wang YT, Piyankarage SC, Williams DL, Thatcher GR (2014) Proteomic profiling of nitrosative stress: protein S-oxidation accompanies S-nitrosylation. ACS Chem Biol 9(3):821–830. https://doi.org/10.1021/cb400547u
Du Y, Zhang H, Zhang X, Lu J, Holmgren A (2013) Thioredoxin 1 is inactivated due to oxidation induced by peroxiredoxin under oxidative stress and reactivated by the glutaredoxin system. J Biol Chem 288(45):32241–32247. https://doi.org/10.1074/jbc.M113.495150
Tao L, Jiao X, Gao E, Lau WB, Yuan Y, Lopez B, Christopher T, RamachandraRao SP, Williams W, Southan G, Sharma K, Koch W, Ma XL (2006) Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation 114(13):1395–1402. https://doi.org/10.1161/CIRCULATIONAHA.106.625061
Engelman R, Ziv T, Arner ESJ, Benhar M (2016) Inhibitory nitrosylation of mammalian thioredoxin reductase 1: molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance. Free Radic Biol Med 97:375–385. https://doi.org/10.1016/j.freeradbiomed.2016.06.032
Zhang X, Lu J, Ren X, Du Y, Zheng Y, Ioannou PV, Holmgren A (2015) Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1. Free Radic Biol Med 89:192–200. https://doi.org/10.1016/j.freeradbiomed.2015.07.010
Biterova EI, Turanov AA, Gladyshev VN, Barycki JJ (2005) Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism. Proc Natl Acad Sci USA 102(42):15018–15023. https://doi.org/10.1073/pnas.0504218102
Wang K, Zhang J, Wang X, Liu X, Zuo L, Bai K, Shang J, Ma L, Liu T, Wang L, Wang W, Ma X, Liu H (2013) Thioredoxin reductase was nitrated in the aging heart after myocardial ischemia/reperfusion. Rejuvenation Res 16(5):377–385. https://doi.org/10.1089/rej.2013.1437
Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M (2014) The glutathione system: a new drug target in neuroimmune disorders. Mol Neurobiol 50:1059–1084
Cebula M, Schmidt EE, Arner ES (2015) TrxR1 as a potent regulator of the Nrf2-Keap1 response system. Antioxid Redox Signal 23(10):823–853. https://doi.org/10.1089/ars.2015.6378
Schmidt EE (2015) Interplay between cytosolic disulfide reductase systems and the Nrf2/Keap1 pathway. Biochem Soc Trans 43(4):632–638. https://doi.org/10.1042/BST20150021
Hansen JM, Watson WH, Jones DP (2004) Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci 82(1):308–317. https://doi.org/10.1093/toxsci/kfh231
Sueblinvong V, Mills ST, Neujahr DC, Go Y-M, Jones DP, Guidot DM (2016) Nuclear thioredoxin-1 overexpression attenuates alcohol-mediated Nrf2 signaling and lung fibrosis. Alcoholism 40(9):1846–1856. https://doi.org/10.1111/acer.13148
Baird L, Dinkova-Kostova AT (2013) Diffusion dynamics of the Keap1-Cullin3 interaction in single live cells. Biochem Biophys Res Commun 433(1):58–65. https://doi.org/10.1016/j.bbrc.2013.02.065
Marinho HS, Real C, Cyrne L, Soares H, Antunes F (2014) Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol 2:535–562. https://doi.org/10.1016/j.redox.2014.02.006
Covas G, Marinho HS, Cyrne L, Antunes F (2013) Activation of Nrf2 by H2O2: de novo synthesis versus nuclear translocation. Methods Enzymol 528:157–171. https://doi.org/10.1016/b978-0-12-405881-1.00009-4
Raninga PV, Trapani GD, Tonissen KF (2014) Cross talk between two antioxidant Systems, thioredoxin and DJ-1: consequences for cancer. Oncoscience 1(1):95–110. https://doi.org/10.18632/oncoscience.12
Liu C, Chen Y, Kochevar IE, Jurkunas UV (2014) Decreased DJ-1 leads to impaired Nrf2-regulated antioxidant defense and increased UV-A-induced apoptosis in corneal endothelial cells. Invest Ophthalmol Vis Sci 55(9):5551–5560. https://doi.org/10.1167/iovs.14-14580
Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP-Y (2006) DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 103(41):15091–15096. https://doi.org/10.1073/pnas.0607260103
Buhrke T, Voss L, Briese A, Stephanowitz H, Krause E, Braeuning A, Lampen A (2018) Oxidative inactivation of the endogenous antioxidant protein DJ-1 by the food contaminants 3-MCPD and 2-MCPD. Arch Toxicol 92(1):289–299. https://doi.org/10.1007/s00204-017-2027-5
Wilson MA (2011) The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal 15(1):111–122. https://doi.org/10.1089/ars.2010.3481
Durigon R, Wang Q, Ceh Pavia E, Grant CM, Lu H (2012) Cytosolic thioredoxin system facilitates the import of mitochondrial small Tim proteins. EMBO Rep 13(10):916–922. https://doi.org/10.1038/embor.2012.116
Morgan B, Lu H (2008) Oxidative folding competes with mitochondrial import of the small Tim proteins. Biochem J 411(1):115–122. https://doi.org/10.1042/bj20071476
Fukai T (2009) Mitochondrial thioredoxin: novel regulator for NADPH oxidase and angiotensin II-induced hypertension. Hypertension 54(2):224–225. https://doi.org/10.1161/HYPERTENSIONAHA.109.134403
Chen B, Meng L, Shen T, Gong H, Qi R, Zhao Y, Sun J, Bao L, Zhao G (2017) Thioredoxin attenuates oxidized low-density lipoprotein induced oxidative stress in human umbilical vein endothelial cells by reducing NADPH oxidase activity. Biochem Biophys Res Commun 490(4):1326–1333. https://doi.org/10.1016/j.bbrc.2017.07.023
Lu J, Holmgren A (2012) Thioredoxin system in cell death progression. Antioxid Redox Signal 17(12):1738–1747. https://doi.org/10.1089/ars.2012.4650
Ostman B, Sjodin A, Michaelsson K, Byberg L (2012) Coenzyme Q10 supplementation and exercise-induced oxidative stress in humans. Nutrition (Burbank, Los Angeles County, Calif) 28(4):403–417. https://doi.org/10.1016/j.nut.2011.07.010
Nagase M, Yamamoto Y, Matsumoto N, Arai Y, Hirose N (2018) Increased oxidative stress and coenzyme Q10 deficiency in centenarians. J Clin Biochem Nutr 63(2):129–136. https://doi.org/10.3164/jcbn.17-124
Kontush A, Reich A, Baum K, Spranger T, Finckh B, Kohlschutter A, Beisiegel U (1997) Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia. Atherosclerosis 129(1):119–126. https://doi.org/10.1016/s0021-9150(96)06021-2
Siemieniuk E, Skrzydlewska E (2005) Coenzyme Q10: its biosynthesis and biological significance in animal organisms and in humans. Postepy Hig Med Dosw(Online) 59:150–159
Katsyuba E, Mottis A, Zietak M, De Franco F, van der Velpen V, Gariani K, Ryu D, Cialabrini L, Matilainen O, Liscio P, Giacchè N, Stokar-Regenscheit N, Legouis D, de Seigneux S, Ivanisevic J, Raffaelli N, Schoonjans K, Pellicciari R, Auwerx J (2018) De novo NAD+ synthesis enhances mitochondrial function and improves health. Nature 563(7731):354–359. https://doi.org/10.1038/s41586-018-0645-6
Lee CF, Caudal A, Abell L, Nagana Gowda GA, Tian R (2019) Targeting NAD+ metabolism as interventions for mitochondrial disease. Sci Rep 9(1):3073. https://doi.org/10.1038/s41598-019-39419-4
Yang Y (1864) (2016) NAD(+) metabolism: Bioenergetics, signaling and manipulation for therapy. Biochim Biophys Acta 12:1787–1800. https://doi.org/10.1016/j.bbapap.2016.06.014
Poljsak B, Milisav I (2016) NAD+ as the link between oxidative stress, inflammation, caloric restriction, exercise, DNA repair, longevity, and health span. Rejuvenation Res 19(5):406–415. https://doi.org/10.1089/rej.2015.1767
Parodi-Rullán RM, Chapa-Dubocq XR, Javadov S (2018) Acetylation of mitochondrial proteins in the heart: the role of SIRT3. Front Physiol. https://doi.org/10.3389/fphys.2018.01094
Tyagi A, Nguyen CU, Chong T, Michel CR, Fritz KS, Reisdorph N, Knaub L, Reusch JEB, Pugazhenthi S (2018) SIRT3 deficiency-induced mitochondrial dysfunction and inflammasome formation in the brain. Sci Rep 8(1):17547. https://doi.org/10.1038/s41598-018-35890-7
Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17(1):41–52. https://doi.org/10.1016/j.ccr.2009.11.023
Ahn B-H, Kim H-S, Song S, Lee IH, Liu J, Vassilopoulos A, Deng C-X, Finkel T (2008) A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA 105(38):14447–14452. https://doi.org/10.1073/pnas.0803790105
Vassilopoulos A, Pennington JD, Andresson T, Rees DM, Bosley AD, Fearnley IM, Ham A, Flynn CR, Hill S, Rose KL, Kim HS, Deng CX, Walker JE, Gius D (2014) SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient- and exercise-induced stress. Antioxid Redox Signal 21(4):551–564. https://doi.org/10.1089/ars.2013.5420
Law IK, Liu L, Xu A, Lam KS, Vanhoutte PM, Che CM, Leung PT, Wang Y (2009) Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. Proteomics 9(9):2444–2456. https://doi.org/10.1002/pmic.200800738
Wu YT, Lee HC, Liao CC (4977bp) Wei YH (2013) Regulation of mitochondrial F(o)F(1)ATPase activity by Sirt3-catalyzed deacetylation and its deficiency in human cells harboring 4977bp deletion of mitochondrial DNA. Biochim Biophys Acta 1:216–227. https://doi.org/10.1016/j.bbadis.2012.10.002
Rahman M, Nirala NK, Singh A, Zhu LJ, Taguchi K, Bamba T, Fukusaki E, Shaw LM, Lambright DG, Acharya JK, Acharya UR (2014) Drosophila Sirt2/mammalian SIRT3 deacetylates ATP synthase beta and regulates complex V activity. J Cell Biol 206(2):289–305. https://doi.org/10.1083/jcb.201404118
Finley LW, Haas W, Desquiret-Dumas V, Wallace DC, Procaccio V, Gygi SP, Haigis MC (2011) Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS ONE 6(8):e23295. https://doi.org/10.1371/journal.pone.0023295
Novgorodov SA, Riley CL, Keffler JA, Yu J, Kindy MS, Macklin WB, Lombard DB, Gudz TI (2016) SIRT3 deacetylates ceramide synthases: implications for mitochondrial dysfunction and brain injury. J Biol Chem 291(4):1957–1973. https://doi.org/10.1074/jbc.M115.668228
Kendrick AA, Choudhury M, Rahman SM, McCurdy CE, Friederich M, Van Hove JL, Watson PA, Birdsey N, Bao J, Gius D, Sack MN, Jing E, Kahn CR, Friedman JE, Jonscher KR (2011) Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem J 433(3):505–514. https://doi.org/10.1042/bj20100791
Traba J, Geiger SS, Kwarteng-Siaw M, Han K, Ra OH, Siegel RM, Gius D, Sack MN (2017) Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3-mediated activation of superoxide dismutase 2. J Biol Chem 292(29):12153–12164. https://doi.org/10.1074/jbc.M117.791715
Geng K, Fu N, Yang X, Xia W (2018) Adjudin delays cellular senescence through Sirt3mediated attenuation of ROS production. Int J Mol Med 42(6):3522–3529. https://doi.org/10.3892/ijmm.2018.3917
Qiao A, Wang K, Yuan Y, Guan Y, Ren X, Li L, Chen X, Li F, Chen AF, Zhou J, Yang J-M, Cheng Y (2016) Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia. Oncotarget 7(28):43390–43400. https://doi.org/10.18632/oncotarget.9717
Morris G, Puri BK, Walder K, Berk M, Stubbs B, Maes M, Carvalho AF (2018) The endoplasmic reticulum stress response in neuroprogressive diseases: emerging pathophysiological role and translational implications. Mol Neurobiol 55(12):8765–8787. https://doi.org/10.1007/s12035-018-1028-6
Fan P, Xie XH, Chen CH, Peng X, Zhang P, Yang C, Wang YT (2019) Molecular regulation mechanisms and interactions between reactive oxygen species and mitophagy. DNA Cell Biol 38(1):10–22. https://doi.org/10.1089/dna.2018.4348
Palacios OM, Carmona JJ, Michan S, Chen KY, Manabe Y, Ward JL 3rd, Goodyear LJ, Tong Q (2009) Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging 1(9):771–783. https://doi.org/10.18632/aging.100075
Fu J, Jin J, Cichewicz RH, Hageman SA, Ellis TK, Xiang L, Peng Q, Jiang M, Arbez N, Hotaling K, Ross CA, Duan W (2012) trans-(-)-epsilon-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington disease. J Biol Chem 287(29):24460–24472. https://doi.org/10.1074/jbc.M112.382226
Rabinovitch RC, Samborska B, Faubert B, Ma EH, Gravel S-P, Andrzejewski S, Raissi TC, Pause A, St.-Pierre J, Jones RG (2017) AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species. Cell Rep 21(1):1–9. https://doi.org/10.1016/j.celrep.2017.09.026
Hinchy EC, Gruszczyk AV, Willows R, Navaratnam N, Hall AR, Bates G, Bright TP, Krieg T, Carling D, Murphy MP (2018) Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly. J Biol Chem. https://doi.org/10.1074/jbc.RA118.002579
Balteau M, Steenbergen AV, Timmermans AD, Dessy C, Behets-Wydemans G, Tajeddine N, Castanares-Zapatero D, Gilon P, Vanoverschelde J-L, Horman S, Hue L, Bertrand L, Beauloye C (2014) AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes. Am J Physiol Heart Circ Physiol 307(8):H1120–H1133. https://doi.org/10.1152/ajpheart.00210.2014
Wu S-B, Wei Y-H (2012) AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases. Biochimica et Biophysica Acta (BBA) 1822(2):233–247. https://doi.org/10.1016/j.bbadis.2011.09.014
Jeon SM, Chandel NS, Hay N (2012) AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485(7400):661–665. https://doi.org/10.1038/nature11066
Liu TF, Vachharajani VT, Yoza BK, McCall CE (2012) NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem 287(31):25758–25769. https://doi.org/10.1074/jbc.M112.362343
Sim WC, Kim DG, Lee W, Sim H, Choi YJ, Lee BH (2019) Activation of SIRT1 by L-serine increases fatty acid oxidation and reverses insulin resistance in C2C12 myotubes (l-serine activates SIRT1 in C2C12 myotubes). Cell Biol Toxicol. https://doi.org/10.1007/s10565-019-09463-x
Qu Q, Zeng F, Liu X, Wang QJ, Deng F (2016) Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis 7:e2226. https://doi.org/10.1038/cddis.2016.132
Morris G, Maes M, Berk M, Puri BK (2019) Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop? Metab Brain Dis 34(2):385–415. https://doi.org/10.1007/s11011-019-0388-6
Jang SY, Kang HT, Hwang ES (2012) Nicotinamide-induced mitophagy: event mediated by high NAD+/NADH ratio and SIRT1 protein activation. J Biol Chem 287(23):19304–19314. https://doi.org/10.1074/jbc.M112.363747
Xu J, Jackson CW, Khoury N, Escobar I, Perez-Pinzon MA (2018) Brain SIRT1 mediates metabolic homeostasis and neuroprotection. Front Endocrinol. https://doi.org/10.3389/fendo.2018.00702
Olmos Y, Sanchez-Gomez FJ, Wild B, Garcia-Quintans N, Cabezudo S, Lamas S, Monsalve M (2013) SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1alpha complex. Antioxid Redox Signal 19(13):1507–1521. https://doi.org/10.1089/ars.2012.4713
St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127(2):397–408. https://doi.org/10.1016/j.cell.2006.09.024
Aquilano K, Baldelli S, Pagliei B, Cannata SM, Rotilio G, Ciriolo MR (2013) p53 orchestrates the PGC-1α-mediated antioxidant response upon mild redox and metabolic imbalance. Antioxid Redox Signal 18(4):386–399. https://doi.org/10.1089/ars.2012.4615
Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RAV, Lazarowski ER, Damian VA, Masliah E, La Spada AR (2012) PGC-1α rescues Huntington’s disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med 4(142):142ra197. https://doi.org/10.1126/scitranslmed.3003799
Baldelli S, Aquilano K, Ciriolo MR (2014) PGC-1α buffers ROS-mediated removal of mitochondria during myogenesis. Cell Death Dis 5(11):e1515–e1515. https://doi.org/10.1038/cddis.2014.458
Miller VJ, Villamena FA, Volek JS (2018) Nutritional ketosis and mitohormesis: potential implications for mitochondrial function and human health. J Nutr Metab 2018:5157645–5157645. https://doi.org/10.1155/2018/5157645
Ploumi C, Daskalaki I, Tavernarakis N (2017) Mitochondrial biogenesis and clearance: a balancing act. FEBS J 284(2):183–195. https://doi.org/10.1111/febs.13820
Scarpulla RC (2011) Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 1813(7):1269–1278. https://doi.org/10.1016/j.bbamcr.2010.09.019
Zhu J, Wang KZQ, Chu CT (2013) After the banquet: mitochondrial biogenesis, mitophagy, and cell survival. Autophagy 9(11):1663–1676. https://doi.org/10.4161/auto.24135
Abid H, Cartier D, Hamieh A, Francois-Bellan AM, Bucharles C, Pothion H, Manecka DL, Leprince J, Adriouch S, Boyer O, Anouar Y, Lihrmann I (2019) AMPK activation of PGC-1alpha/NRF-1-dependent SELENOT gene transcription promotes PACAP-induced neuroendocrine cell differentiation through tolerance to oxidative stress. Mol Neurobiol 56(6):4086–4101. https://doi.org/10.1007/s12035-018-1352-x
Yu L, Yang SJ (2010) AMP-activated protein kinase mediates activity-dependent regulation of peroxisome proliferator-activated receptor gamma coactivator-1alpha and nuclear respiratory factor 1 expression in rat visual cortical neurons. Neuroscience 169(1):23–38. https://doi.org/10.1016/j.neuroscience.2010.04.063
Barchiesi A, Vascotto C (2019) Transcription, processing, and decay of mitochondrial RNA in health and disease. Int J Mol Sci 20(9):2221. https://doi.org/10.3390/ijms20092221
Aquilano K, Baldelli S, Pagliei B, Ciriolo M (2013) Extranuclear localization of SIRT1 and PGC-1: an insight into possible roles in diseases associated with mitochondrial dysfunction. Curr Mol Med 13(1):140–154. https://doi.org/10.2174/156652413804486241
Pagliei B, Aquilano K, Baldelli S, Ciriolo MR (2013) Garlic-derived diallyl disulfide modulates peroxisome proliferator activated receptor gamma co-activator 1 alpha in neuroblastoma cells. Biochem Pharmacol 85(3):335–344. https://doi.org/10.1016/j.bcp.2012.11.007
Aquilano K, Vigilanza P, Baldelli S, Pagliei B, Rotilio G, Ciriolo MR (2010) Peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem 285(28):21590–21599. https://doi.org/10.1074/jbc.M109.070169
Austin S, St-Pierre J (2012) PGC1α and mitochondrial metabolism – emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci 125(21):4963–4971. https://doi.org/10.1242/jcs.113662
Austin S, Klimcakova E, St-Pierre J (2011) Impact of PGC-1alpha on the topology and rate of superoxide production by the mitochondrial electron transport chain. Free Radic Biol Med 51(12):2243–2248. https://doi.org/10.1016/j.freeradbiomed.2011.08.036
Hoeks J, Arany Z, Phielix E, Moonen-Kornips E, Hesselink MK, Schrauwen P (2012) Enhanced lipid-but not carbohydrate-supported mitochondrial respiration in skeletal muscle of PGC-1alpha overexpressing mice. J Cell Physiol 227(3):1026–1033. https://doi.org/10.1002/jcp.22812
Finkel T (2006) Cell biology: a clean energy programme. Nature 444(7116):151–152. https://doi.org/10.1038/444151a
Kukat C, Davies KM, Wurm CA, Spåhr H, Bonekamp NA, Kühl I, Joos F, Polosa PL, Park CB, Posse V, Falkenberg M, Jakobs S, Kühlbrandt W, Larsson N-G (2015) Cross-strand binding of TFAM to a single mtDNA molecule forms the mitochondrial nucleoid. Proc Natl Acad Sci USA 112(36):11288–11293. https://doi.org/10.1073/pnas.1512131112
Picca A, Lezza AM (2015) Regulation of mitochondrial biogenesis through TFAM-mitochondrial DNA interactions: useful insights from aging and calorie restriction studies. Mitochondrion 25:67–75. https://doi.org/10.1016/j.mito.2015.10.001
Olmos Y, Valle I, Borniquel S, Tierrez A, Soria E, Lamas S, Monsalve M (2009) Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes. J Biol Chem 284(21):14476–14484. https://doi.org/10.1074/jbc.M807397200
Klotz L-O, Sánchez-Ramos C, Prieto-Arroyo I, Urbánek P, Steinbrenner H, Monsalve M (2015) Redox regulation of FoxO transcription factors. Redox Biol 6:51–72. https://doi.org/10.1016/j.redox.2015.06.019
Valle I, Álvarez-Barrientos A, Arza E, Lamas S, Monsalve M (2005) PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res 66(3):562–573. https://doi.org/10.1016/j.cardiores.2005.01.026
Wang Y, Zhou Y, Graves DT (2014) FOXO transcription factors: their clinical significance and regulation. Biomed Res Int 2014:13. https://doi.org/10.1155/2014/925350
Yun H, Park S, Kim M-J, Yang WK, Im DU, Yang KR, Hong J, Choe W, Kang I, Kim SS, Ha J (2014) AMP-activated protein kinase mediates the antioxidant effects of resveratrol through regulation of the transcription factor FoxO1. FEBS J 281(19):4421–4438. https://doi.org/10.1111/febs.12949
Zhao X, Petursson F, Viollet B, Lotz M, Terkeltaub R, Liu-Bryan R (2014) Peroxisome proliferator-activated receptor gamma coactivator 1alpha and FoxO3A mediate chondroprotection by AMP-activated protein kinase. Arthritis Rheumatol (Hoboken, NJ) 66(11):3073–3082. https://doi.org/10.1002/art.38791
Peserico A, Chiacchiera F, Grossi V, Matrone A, Latorre D, Simonatto M, Fusella A, Ryall JG, Finley LW, Haigis MC, Villani G, Puri PL, Sartorelli V, Simone C (2013) A novel AMPK-dependent FoxO3A-SIRT3 intramitochondrial complex sensing glucose levels. Cell Mol Life Sci 70(11):2015–2029. https://doi.org/10.1007/s00018-012-1244-6
Webb AE, Brunet A (2014) FOXO transcription factors: key regulators of cellular quality control. Trends Biochem Sci 39(4):159–169. https://doi.org/10.1016/j.tibs.2014.02.003
Palikaras K, Tavernarakis N (2014) Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis. Exp Gerontol 56:182–188. https://doi.org/10.1016/j.exger.2014.01.021
Morris G, Berk M (2016) The putative use of lithium in Alzheimer's disease. Curr Alzheimer Res 13(8):853–861
Audesse AJ, Dhakal S, Hassell LA, Gardell Z, Nemtsova Y, Webb AE (2019) FOXO3 directly regulates an autophagy network to functionally regulate proteostasis in adult neural stem cells. PLoS Genet 15(4):e1008097. https://doi.org/10.1371/journal.pgen.1008097
Mei Y, Zhang Y, Yamamoto K, Xie W, Mak TW, You H (2009) FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation. Proc Natl Acad Sci USA 106(13):5153–5158. https://doi.org/10.1073/pnas.0901104106
Tan S, Wong E (2017) Mitophagy transcriptome: mechanistic insights into polyphenol-mediated mitophagy. Oxid Med Cell Longev 2017:9028435–9028435. https://doi.org/10.1155/2017/9028435
Obsil T, Obsilova V (2011) Structural basis for DNA recognition by FOXO proteins. Biochimica et Biophysica Acta (BBA) 1813(11):1946–1953. https://doi.org/10.1016/j.bbamcr.2010.11.025
Tang BL (2016) Sirt1 and the mitochondria. Mol Cells 39(2):87–95. https://doi.org/10.14348/molcells.2016.2318
Li P, Liu Y, Burns N, Zhao K-S, Song R (2017) SIRT1 is required for mitochondrial biogenesis reprogramming in hypoxic human pulmonary arteriolar smooth muscle cells. Int J Mol Med 39(5):1127–1136. https://doi.org/10.3892/ijmm.2017.2932
Ma S, Zhao Y, Sun J, Mu P, Deng Y (2018) miR449a/SIRT1/PGC-1α is necessary for mitochondrial biogenesis induced by T-2 toxin. Front Pharmacol. https://doi.org/10.3389/fphar.2017.00954
Das S, Mitrovsky G, Vasanthi HR, Das DK (2014) Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN. Oxid Med Cell Longev 2014:13. https://doi.org/10.1155/2014/345105
Papa L, Germain D (2014) SirT3 regulates the mitochondrial unfolded protein response. Mol Cell Biol 34(4):699–710. https://doi.org/10.1128/mcb.01337-13
Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331(6016):456–461. https://doi.org/10.1126/science.1196371
Lee Y, Stevens DA, Kang SU, Jiang H, Lee YI, Ko HS, Scarffe LA, Umanah GE, Kang H, Ham S, Kam TI, Allen K, Brahmachari S, Kim JW, Neifert S, Yun SP, Fiesel FC, Springer W, Dawson VL, Shin JH, Dawson TM (2017) PINK1 primes Parkin-mediated ubiquitination of PARIS in dopaminergic neuronal survival. Cell Rep 18(4):918–932. https://doi.org/10.1016/j.celrep.2016.12.090
Ivankovic D, Chau KY, Schapira AH, Gegg ME (2016) Mitochondrial and lysosomal biogenesis are activated following PINK1/parkin-mediated mitophagy. J Neurochem 136(2):388–402. https://doi.org/10.1111/jnc.13412
Taherzadeh-Fard E, Saft C, Akkad DA, Wieczorek S, Haghikia A, Chan A, Epplen JT, Arning L (2011) PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Mol Neurodegener 6(1):32–32. https://doi.org/10.1186/1750-1326-6-32
Zheng J, Shi L, Liang F, Xu W, Li T, Gao L, Sun Z, Yu J, Zhang J (2018) Sirt3 ameliorates oxidative stress and mitochondrial dysfunction after intracerebral hemorrhage in diabetic rats. Front Neurosci. https://doi.org/10.3389/fnins.2018.00414
Yin J, Guo J, Zhang Q, Cui L, Zhang L, Zhang T, Zhao J, Li J, Middleton A, Carmichael PL, Peng S (2018) Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway. Toxicol In Vitro 51:1–10. https://doi.org/10.1016/j.tiv.2018.05.001
Yang K, Huang R, Fujihira H, Suzuki T, Yan N (2018) N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1. J Exp Med 215(10):2600–2616. https://doi.org/10.1084/jem.20180783
Gureev AP, Shaforostova EA, Popov VN (2019) Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1α signaling pathways. Front Genet. https://doi.org/10.3389/fgene.2019.00435
Suliman HB, Keenan JE, Piantadosi CA (2017) Mitochondrial quality-control dysregulation in conditional HO-1(−/−) mice. JCI Insight 2(3):e89676–e89676. https://doi.org/10.1172/jci.insight.89676
Chow H-M, Cheng A, Song X, Swerdel MR, Hart RP, Herrup K (2019) ATM is activated by ATP depletion and modulates mitochondrial function through NRF1. J Cell Biol 218(3):909–928. https://doi.org/10.1083/jcb.201806197
Gugneja S, Scarpulla RC (1997) Serine phosphorylation within a concise amino-terminal domain in nuclear respiratory factor 1 enhances DNA binding. J Biol Chem 272(30):18732–18739. https://doi.org/10.1074/jbc.272.30.18732
Lu Y, Fujioka H, Joshi D, Li Q, Sangwung P, Hsieh P, Zhu J, Torio J, Sweet D, Wang L, Chiu SY, Croniger C, Liao X, Jain MK (2018) Mitophagy is required for brown adipose tissue mitochondrial homeostasis during cold challenge. Sci Rep 8(1):8251. https://doi.org/10.1038/s41598-018-26394-5
Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8(1):e1000298. https://doi.org/10.1371/journal.pbio.1000298
Zhang T, Wu P, Budbazar E, Zhu Q, Sun C, Mo J, Peng J, Gospodarev V, Tang J, Shi H, Zhang JH (2019) Mitophagy reduces oxidative stress via Keap1 (kelch-like epichlorohydrin-associated protein 1)/Nrf2 (nuclear factor-E2-related factor 2)/PHB2 (prohibitin 2) pathway after subarachnoid hemorrhage in rats. Stroke 50(4):978–988. https://doi.org/10.1161/strokeaha.118.021590
Palikaras K, Lionaki E, Tavernarakis N (2015) Balancing mitochondrial biogenesis and mitophagy to maintain energy metabolism homeostasis. Cell Death Differ 22(9):1399–1401. https://doi.org/10.1038/cdd.2015.86
O'Mealey GB, Plafker KS, Berry WL, Janknecht R, Chan JY, Plafker SM (2017) A PGAM5-KEAP1-Nrf2 complex is required for stress-induced mitochondrial retrograde trafficking. J Cell Sci 130(20):3467–3480. https://doi.org/10.1242/jcs.203216
Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT (2012) Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. New Engl J Med 367(12):1098–1107. https://doi.org/10.1056/NEJMoa1114287
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT (2012) Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. New Engl J Med 367(12):1087–1097. https://doi.org/10.1056/NEJMoa1206328
Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, Ellrichmann G, Bruck W, Dawson K, Goelz S, Wiese S, Scannevin RH, Lukashev M, Gold R (2011) Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134(Pt 3):678–692. https://doi.org/10.1093/brain/awq386
da Costa RM, Rodrigues D, Pereira CA, Silva JF, Alves JV, Lobato NS, Tostes RC (2019) Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases. Front Pharmacol 10:382–382. https://doi.org/10.3389/fphar.2019.00382
Axelsson AS, Tubbs E, Mecham B, Chacko S, Nenonen HA, Tang Y, Fahey JW, Derry JMJ, Wollheim CB, Wierup N, Haymond MW, Friend SH, Mulder H, Rosengren AH (2017) Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Sci Transl Med 9(394):4477. https://doi.org/10.1126/scitranslmed.aah4477
Patel B, Mann GE, Chapple SJ (2018) Concerted redox modulation by sulforaphane alleviates diabetes and cardiometabolic syndrome. Free Radic Biol Med 122:150–160. https://doi.org/10.1016/j.freeradbiomed.2018.02.004
Xie K, Liu L, Yu Y, Wang G (2014) Hydrogen gas presents a promising therapeutic strategy for sepsis. Biomed Res Int 2014:807635–807635. https://doi.org/10.1155/2014/807635
Todorovic M, Wood SA (1996) Mellick GD (2016) Nrf2: a modulator of Parkinson's disease? J Neural Transmission 123(6):611–619. https://doi.org/10.1007/s00702-016-1563-0
Ahuja M, Ammal Kaidery N, Yang L, Calingasan N, Smirnova N, Gaisin A, Gaisina IN, Gazaryan I, Hushpulian DM, Kaddour-Djebbar I, Bollag WB, Morgan JC, Ratan RR, Starkov AA, Beal MF, Thomas B (2016) Distinct Nrf2 signaling mechanisms of fumaric acid esters and their role in neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced experimental Parkinson's-like disease. J Neurosci 36(23):6332–6351. https://doi.org/10.1523/jneurosci.0426-16.2016
Tufekci KU, Civi Bayin E, Genc S, Genc K (2011) The Nrf2/ARE pathway: a promising target to counteract mitochondrial dysfunction in Parkinson’s disease. Parkinson’s Dis. https://doi.org/10.4061/2011/314082
Ventura-Clapier R, Garnier A, Veksler V (2008) Transcriptional control of mitochondrial biogenesis: the central role of PGC-1α. Cardiovasc Res 79(2):208–217. https://doi.org/10.1093/cvr/cvn098
Steele ML, Fuller S, Patel M, Kersaitis C, Ooi L, Munch G (2013) Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells. Redox Biol 1:441–445. https://doi.org/10.1016/j.redox.2013.08.006
Ishii T, Mann GE (2014) Redox status in mammalian cells and stem cells during culture in vitro: critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance. Redox Biol 2:786–794. https://doi.org/10.1016/j.redox.2014.04.008
Banning A, Deubel S, Kluth D, Zhou Z, Brigelius-Flohe R (2005) The GI-GPx gene is a target for Nrf2. Mol Cell Biol 25(12):4914–4923. https://doi.org/10.1128/mcb.25.12.4914-4923.2005
Jablonska E, Gromadzinska J, Peplonska B, Fendler W, Reszka E, Krol MB, Wieczorek E, Bukowska A, Gresner P, Galicki M, Zambrano Quispe O, Morawiec Z, Wasowicz W (2015) Lipid peroxidation and glutathione peroxidase activity relationship in breast cancer depends on functional polymorphism of GPX1. BMC Cancer 15:657. https://doi.org/10.1186/s12885-015-1680-4
Bartolini D, Commodi J, Piroddi M, Incipini L, Sancineto L, Santi C, Galli F (2015) Glutathione S-transferase pi expression regulates the Nrf2-dependent response to hormetic diselenides. Free Radical Biol Med 88:466–480. https://doi.org/10.1016/j.freeradbiomed.2015.06.039
Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, Wakabayashi N, Fujii J, Myers A, Biswal S (2009) Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radical Biol Med 46(4):443–453. https://doi.org/10.1016/j.freeradbiomed.2008.10.040
Tanito M, Agbaga MP, Anderson RE (2007) Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radic Biol Med 42(12):1838–1850. https://doi.org/10.1016/j.freeradbiomed.2007.03.018
Im J-Y, Lee K-W, Woo J-M, Junn E, Mouradian MM (2012) DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum Mol Genet 21(13):3013–3024. https://doi.org/10.1093/hmg/dds131
Li Q, Wall SB, Ren C, Velten M, Hill CL, Locy ML, Rogers LK, Tipple TE (2016) Thioredoxin reductase inhibition attenuates neonatal hyperoxic lung injury and enhances nuclear factor E2-related factor 2 activation. Am J Respir Cell Mol Biol 55(3):419–428. https://doi.org/10.1165/rcmb.2015-0228OC
Holmström KM, Kostov RV, Dinkova-Kostova AT (2016) The multifaceted role of Nrf2 in mitochondrial function. Curr Opin Toxicol 1:80–91. https://doi.org/10.1016/j.cotox.2016.10.002
Dinkova-Kostova AT, Abramov AY (2015) The emerging role of Nrf2 in mitochondrial function. Free Radic Biol Med 88(Pt B):179–188. https://doi.org/10.1016/j.freeradbiomed.2015.04.036
Ushida Y, Talalay P (2013) Sulforaphane accelerates acetaldehyde metabolism by inducing aldehyde dehydrogenases: relevance to ethanol intolerance. Alcohol Alcohol 48(5):526–534. https://doi.org/10.1093/alcalc/agt063
Heiss EH, Schachner D, Zimmermann K, Dirsch VM (2013) Glucose availability is a decisive factor for Nrf2-mediated gene expression. Redox Biol 1(1):359–365. https://doi.org/10.1016/j.redox.2013.06.001
Holmström KM, Baird L, Zhang Y, Hargreaves I, Chalasani A, Land JM, Stanyer L, Yamamoto M, Dinkova-Kostova AT, Abramov AY (2013) Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol Open 2(8):761–770. https://doi.org/10.1242/bio.20134853
Kincaid B, Bossy-Wetzel E (2013) Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration. Front Aging Neurosci. https://doi.org/10.3389/fnagi.2013.00048
Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C (2008) Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 382(3):790–801. https://doi.org/10.1016/j.jmb.2008.07.048
Han SJ, Jang H-S, Noh MR, Kim J, Kong MJ, Kim JI, Park J-W, Park KM (2017) Mitochondrial NADP+-dependent isocitrate dehydrogenase deficiency exacerbates mitochondrial and cell damage after kidney ischemia-reperfusion injury. J Am Soc Nephrol 28(4):1200–1215. https://doi.org/10.1681/asn.2016030349
McCammon MT, Epstein CB, Przybyla-Zawislak B, McAlister-Henn L, Butow RA (2003) Global transcription analysis of Krebs tricarboxylic acid cycle mutants reveals an alternating pattern of gene expression and effects on hypoxic and oxidative genes. Mol Biol Cell 14(3):958–972. https://doi.org/10.1091/mbc.e02-07-0422
Damdimopoulos AE, Miranda-Vizuete A, Pelto-Huikko M, Gustafsson JA, Spyrou G (2002) Human mitochondrial thioredoxin Involvement in mitochondrial membrane potential and cell death. J Biol Chem 277(36):33249–33257. https://doi.org/10.1074/jbc.M203036200
Kang I, Chu CT, Kaufman BA (2018) The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms. FEBS Lett 592(5):793–811. https://doi.org/10.1002/1873-3468.12989
Harbauer AB, Zahedi RP, Sickmann A, Pfanner N, Meisinger C (2014) The protein import machinery of mitochondria-a regulatory hub in metabolism, stress, and disease. Cell Metab 19(3):357–372. https://doi.org/10.1016/j.cmet.2014.01.010
Dudek J, Rehling P, van der Laan M (2013) Mitochondrial protein import: common principles and physiological networks. Biochimica et Biophysica Acta (BBA) 1833(2):274–285. https://doi.org/10.1016/j.bbamcr.2012.05.028
Wiedemann N, Pfanner N (2017) Mitochondrial machineries for protein import and assembly. Annu Rev Biochem 86(1):685–714. https://doi.org/10.1146/annurev-biochem-060815-014352
Craig EA (2018) Hsp70 at the membrane: driving protein translocation. BMC Biol 16(1):11–11. https://doi.org/10.1186/s12915-017-0474-3
Grunwald MS, Pires AS, Zanotto-Filho A, Gasparotto J, Gelain DP, Demartini DR, Schöler CM, de Bittencourt PIH, Moreira JCF (2014) The oxidation of HSP70 is associated with functional impairment and lack of stimulatory capacity. Cell Stress Chaperones 19(6):913–925. https://doi.org/10.1007/s12192-014-0516-5
Marozkina NV, Yemen S, Borowitz M, Liu L, Plapp M, Sun F, Islam R, Erdmann-Gilmore P, Townsend RR, Lichti CF, Mantri S, Clapp PW, Randell SH, Gaston B, Zaman K (2010) Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy. Proc Natl Acad Sci USA 107(25):11393–11398. https://doi.org/10.1073/pnas.0909128107
Davila A, Liu L, Chellappa K, Redpath P, Nakamaru-Ogiso E, Paolella LM, Zhang Z, Migaud ME, Rabinowitz JD, Baur JA (2018) Nicotinamide adenine dinucleotide is transported into mammalian mitochondria. eLife 7:e33246. https://doi.org/10.7554/eLife.33246
Ribas V, García-Ruiz C, Fernández-Checa JC (2014) Glutathione and mitochondria. Front Pharmacol 5:151–151. https://doi.org/10.3389/fphar.2014.00151
Dinkova-Kostova AT, Kostov RV, Kazantsev AG (2018) The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS J 285(19):3576–3590. https://doi.org/10.1111/febs.14379
Murata H, Takamatsu H, Liu S, Kataoka K, Huh NH, Sakaguchi M (2015) NRF2 regulates PINK1 expression under oxidative stress conditions. PLoS ONE 10(11):e0142438. https://doi.org/10.1371/journal.pone.0142438
Leites EP, Morais VA (2018) Mitochondrial quality control pathways: PINK1 acts as a gatekeeper. Biochem Biophys Res Commun 500(1):45–50. https://doi.org/10.1016/j.bbrc.2017.06.096
Yoshino J, Baur JA, Imai S-I (2018) NAD(+) intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab 27(3):513–528. https://doi.org/10.1016/j.cmet.2017.11.002
Poddar SK, Sifat AE, Haque S, Nahid NA, Chowdhury S, Mehedi I (2019) Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule. Biomolecules 9(1):34. https://doi.org/10.3390/biom9010034
Chi Y, Sauve AA (2013) Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection. Curr Opin Clin Nutr Metab Care 16(6):657–661. https://doi.org/10.1097/MCO.0b013e32836510c0
Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DR (2018) Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun 9(1):1286. https://doi.org/10.1038/s41467-018-03421-7
Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, Redpath P, Migaud ME, Apte RS, Uchida K, Yoshino J, Imai SI (2016) Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab 24(6):795–806. https://doi.org/10.1016/j.cmet.2016.09.013
Stein LR, Imai S (2014) Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging. EMBO J 33(12):1321–1340. https://doi.org/10.1002/embj.201386917
Yoon MJ, Yoshida M, Johnson S, Takikawa A, Usui I, Tobe K, Nakagawa T, Yoshino J, Imai S (2015) SIRT1-mediated eNAMPT secretion from adipose tissue regulates hypothalamic NAD+ and function in mice. Cell Metab 21(5):706–717. https://doi.org/10.1016/j.cmet.2015.04.002
Wang X, Hu X, Yang Y, Takata T, Sakurai T (2016) Nicotinamide mononucleotide protects against beta-amyloid oligomer-induced cognitive impairment and neuronal death. Brain Res 1643:1–9. https://doi.org/10.1016/j.brainres.2016.04.060
Yao Z, Yang W, Gao Z, Jia P (2017) Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease. Neurosci Lett 647:133–140. https://doi.org/10.1016/j.neulet.2017.03.027
Wei C-C, Kong Y-Y, Li G-Q, Guan Y-F, Wang P, Miao C-Y (2017) Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway. Sci Rep 7(1):717. https://doi.org/10.1038/s41598-017-00851-z
Yoshino J, Mills KF, Yoon MJ, Imai S (2011) Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 14(4):528–536. https://doi.org/10.1016/j.cmet.2011.08.014
Stromsdorfer KL, Yamaguchi S, Yoon MJ, Moseley AC, Franczyk MP, Kelly SC, Qi N, Imai S, Yoshino J (2016) NAMPT-Mediated NAD(+) biosynthesis in adipocytes regulates adipose tissue function and multi-organ insulin sensitivity in mice. Cell Rep 16(7):1851–1860. https://doi.org/10.1016/j.celrep.2016.07.027
Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hubbard BP, Mercken EM, Palmeira CM, de Cabo R, Rolo AP, Turner N, Bell EL, Sinclair DA (2013) Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155(7):1624–1638. https://doi.org/10.1016/j.cell.2013.11.037
Lee CF, Chavez JD, Garcia-Menendez L, Choi Y, Roe ND, Chiao YA, Edgar JS, Goo YA, Goodlett DR, Bruce JE, Tian R (2016) Normalization of NAD+ redox balance as a therapy for heart failure. Circulation 134(12):883–894. https://doi.org/10.1161/circulationaha.116.022495
Long AN, Owens K, Schlappal AE, Kristian T, Fishman PS, Schuh RA (2015) Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model. BMC Neurol 15:19–19. https://doi.org/10.1186/s12883-015-0272-x
Russo R, Cavaliere F, Rombola L, Gliozzi M, Cerulli A, Nucci C, Fazzi E, Bagetta G, Corasaniti MT, Morrone LA (2008) Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection. Prog Brain Res 173:575–582. https://doi.org/10.1016/s0079-6123(08)01139-4
Nucci C, Tartaglione R, Cerulli A, Mancino R, Spano A, Cavaliere F, Rombola L, Bagetta G, Corasaniti MT, Morrone LA (2007) Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int Rev Neurobiol 82:397–406. https://doi.org/10.1016/s0074-7742(07)82022-8
Lee D, Shim MS, Kim KY, Noh YH, Kim H, Kim SY, Weinreb RN, Ju WK (2014) Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma. Invest Ophthalmol Vis Sci 55(2):993–1005. https://doi.org/10.1167/iovs.13-12564
Lee D, Kim K-Y, Shim MS, Kim SY, Ellisman MH, Weinreb RN, Ju W-K (2014) Coenzyme Q10 ameliorates oxidative stress and prevents mitochondrial alteration in ischemic retinal injury. Apoptosis 19(4):603–614. https://doi.org/10.1007/s10495-013-0956-x
Zhai J, Bo Y, Lu Y, Liu C, Zhang L (2017) Effects of coenzyme Q10 on markers of inflammation: a systematic review and meta-analysis. PLoS ONE 12(1):e0170172. https://doi.org/10.1371/journal.pone.0170172
Fan L, Feng Y, Chen GC, Qin LQ, Fu CL, Chen LH (2017) Effects of coenzyme Q10 supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 119:128–136. https://doi.org/10.1016/j.phrs.2017.01.032
Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Khodadadi B, Jazayeri S, Gohari MR, Aryaeian N (2015) Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial. Nutr Neurosci 18(4):169–176. https://doi.org/10.1179/1476830513y.0000000106
Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Jazayeri S, Reza Gohari M (2013) Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis. Int J Neurosci 123(11):776–782. https://doi.org/10.3109/00207454.2013.801844
Erol B, Bozlu M, Hanci V, Tokgoz H, Bektas S, Mungan G (2010) Coenzyme Q10 treatment reduces lipid peroxidation, inducible and endothelial nitric oxide synthases, and germ cell-specific apoptosis in a rat model of testicular ischemia/reperfusion injury. Fertil Steril 93(1):280–282. https://doi.org/10.1016/j.fertnstert.2009.07.981
Ulla A, Mohamed MK, Sikder B, Rahman AT, Sumi FA, Hossain M, Reza HM, Rahman GMS, Alam MA (2017) Coenzyme Q10 prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats. BMC Pharmacol Toxicol 18(1):29. https://doi.org/10.1186/s40360-017-0136-7
Fouad AA, Jresat I (2012) Hepatoprotective effect of coenzyme Q10 in rats with acetaminophen toxicity. Environ Toxicol Pharmacol 33(2):158–167. https://doi.org/10.1016/j.etap.2011.12.011
Kabel AM, Elkhoely AA (2017) Ameliorative effect of coenzyme Q10 and/or candesartan on carboplatin-induced nephrotoxicity: roles of apoptosis, transforming growth factor-Β1, nuclear factor kappa-B and the Nrf2/HO-1 pathway. Asian Pac J Cancer Prev 18(6):1629–1636. https://doi.org/10.22034/APJCP.2017.18.6.1629
Khodir AE, Atef H, Said E, ElKashef HA, Salem HA (2017) Implication of Nrf2/HO-1 pathway in the coloprotective effect of coenzyme Q10 against experimentally induced ulcerative colitis. Inflammopharmacology 25(1):119–135. https://doi.org/10.1007/s10787-016-0305-0
Pala R, Orhan C, Tuzcu M, Sahin N, Ali S, Cinar V, Atalay M, Sahin K (2016) Coenzyme Q10 supplementation modulates NFkappaB and Nrf2 pathways in exercise training. J Sports Sci Med 15(1):196–203
Choi H-K, Pokharel YR, Lim SC, Han H-K, Ryu CS, Kim SK, Kwak MK, Kang KW (2009) Inhibition of liver fibrosis by solubilized coenzyme Q10: role of Nrf2 activation in inhibiting transforming growth factor-β1 expression. Toxicol Appl Pharmacol 240(3):377–384. https://doi.org/10.1016/j.taap.2009.07.030
Tian G, Sawashita J, Kubo H, Nishio S-y, Hashimoto S, Suzuki N, Yoshimura H, Tsuruoka M, Wang Y, Liu Y, Luo H, Xu Z, Mori M, Kitano M, Hosoe K, Takeda T, Usami S-i, Higuchi K (2014) Ubiquinol-10 supplementation activates mitochondria functions to decelerate senescence in senescence-accelerated mice. Antioxid Redox Signal 20(16):2606–2620. https://doi.org/10.1089/ars.2013.5406
Morris G, Berk M, Walder K, Maes M (2015) Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med 13(1):28
Huo J, Xu Z, Hosoe K, Kubo H, Miyahara H, Dai J, Mori M, Sawashita J, Higuchi K (2018) Coenzyme Q10 prevents senescence and dysfunction caused by oxidative stress in vascular endothelial cells. Oxid Med Cell Longev 2018:3181759. https://doi.org/10.1155/2018/3181759
Tsai K-L, Huang Y-H, Kao C-L, Yang D-M, Lee H-C, Chou H-Y, Chen Y-C, Chiou G-Y, Chen L-H, Yang Y-P, Chiu T-H, Tsai C-S, Ou H-C, Chiou S-H (2012) A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways. J Nutr Biochem 23(5):458–468. https://doi.org/10.1016/j.jnutbio.2011.01.011
Awad Agape M, Bradley Michelle C, Fernández-del-Río L, Nag A, Tsui HS, Clarke Catherine F (2018) Coenzyme Q10 deficiencies: pathways in yeast and humans. Essays Biochem 62(3):361–376. https://doi.org/10.1042/ebc20170106
Murphy MP, Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629–656. https://doi.org/10.1146/annurev.pharmtox.47.120505.105110
McManus MJ, Murphy MP, Franklin JL (2011) The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J Neurosci 31(44):15703–15715. https://doi.org/10.1523/jneurosci.0552-11.2011
Maguire Á, Hargreaves A, Gill M (2018) The impact of coenzyme Q10 on the cognitive deficits and symptoms of schizophrenia: protocol and baseline data of a randomised, placebo-controlled study. Schizophrenia Bull 44(Suppl 1):S357–S357. https://doi.org/10.1093/schbul/sby018.870
Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009) Lower plasma coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett 30(4):462–469
McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS Jr, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WLA, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M, Huntington Study Group CI, Coordinators (2017) A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 88(2):152–159. https://doi.org/10.1212/WNL.0000000000003478
Hernández-Camacho JD, Bernier M, López-Lluch G, Navas P (2018) Coenzyme Q(10) supplementation in aging and disease. Front Physiol 9:44–44. https://doi.org/10.3389/fphys.2018.00044
Wright DJ, Renoir T, Smith ZM, Frazier AE, Francis PS, Thorburn DR, McGee SL, Hannan AJ, Gray LJ (2015) N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease. Transl Psychiatry 5(1):e492–e492. https://doi.org/10.1038/tp.2014.131
Tardiolo G, Bramanti P, Mazzon E (2018) Overview on the effects of N-acetylcysteine in neurodegenerative diseases. Molecules (Basel, Switzerland) 23(12):3305. https://doi.org/10.3390/molecules23123305
Aldbass AM, Bhat RS, El-Ansary A (2013) Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats. J Neuroinflamm 10(1):837. https://doi.org/10.1186/1742-2094-10-42
Saleh AAS (2015) Anti-neuroinflammatory and antioxidant effects of N-acetyl cysteine in long-term consumption of artificial sweetener aspartame in the rat cerebral cortex. J Basic Appl Zool 72:73–80. https://doi.org/10.1016/j.jobaz.2015.05.001
Schneider R, Bandiera S, Souza DG, Bellaver B, Caletti G, Quincozes-Santos A, Elisabetsky E, Gomez R (2017) N-acetylcysteine prevents alcohol related neuroinflammation in rats. Neurochem Res 42(8):2135–2141. https://doi.org/10.1007/s11064-017-2218-8
Sevillano S, de la Mano AM, Manso MA, Orfao A, De Dios I (2003) N-acetylcysteine prevents intra-acinar oxygen free radical production in pancreatic duct obstruction-induced acute pancreatitis. Biochimica et Biophysica Acta (BBA) 1639(3):177–184. https://doi.org/10.1016/j.bbadis.2003.09.003
Gupta SK, Kamendulis LM, Clauss MA, Liu Z (2016) A randomized, placebo-controlled pilot trial of N-acetylcysteine on oxidative stress and endothelial function in HIV-infected older adults receiving ART: NAC in HIV. AIDS (London, England) 30(15):2389–2391. https://doi.org/10.1097/QAD.0000000000001222
Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, McDougle CJ, Erickson CA (2016) A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. Mol Autism 7:26. https://doi.org/10.1186/s13229-016-0088-6
De Rosa SC, Zaretsky MD, Dubs JG, Roederer M, Anderson M, Green A, Mitra D, Watanabe N, Nakamura H, Tjioe I, Deresinski SC, Moore WA, Ela SW, Parks D, Herzenberg LA, Herzenberg LA (2000) N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest 30(10):915–929
Soltan-Sharifi MS, Mojtahedzadeh M, Najafi A, Reza Khajavi M, Reza Rouini M, Moradi M, Mohammadirad A, Abdollahi M (2007) Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. Hum Exp Toxicol 26(9):697–703. https://doi.org/10.1177/0960327107083452
Majano PL, Medina J, Zubia I, Sunyer L, Lara-Pezzi E, Maldonado-Rodriguez A, Lopez-Cabrera M, Moreno-Otero R (2004) N-Acetyl-cysteine modulates inducible nitric oxide synthase gene expression in human hepatocytes. J Hepatol 40(4):632–637. https://doi.org/10.1016/j.jhep.2003.12.009
Whitehead NP, Pham C, Gervasio OL, Allen DG (2008) N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 586(7):2003–2014. https://doi.org/10.1113/jphysiol.2007.148338
Garcia-Roman R, Salazar-Gonzalez D, Rosas S, Arellanes-Robledo J, Beltran-Ramirez O, Fattel-Fazenda S, Villa-Trevino S (2008) The differential NF-kB modulation by S-adenosyl-L-methionine, N-acetylcysteine and quercetin on the promotion stage of chemical hepatocarcinogenesis. Free Radical Res 42(4):331–343. https://doi.org/10.1080/10715760802005169
Ji L, Liu R, Zhang XD, Chen HL, Bai H, Wang X, Zhao HL, Liang X, Hai CX (2010) N-acetylcysteine attenuates phosgene-induced acute lung injury via up-regulation of Nrf2 expression. Inhalation Toxicol 22(7):535–542. https://doi.org/10.3109/08958370903525183
Zhang L, Zhu Z, Liu J, Zhu Z, Hu Z (2014) Protective effect of N-acetylcysteine (NAC) on renal ischemia/reperfusion injury through Nrf2 signaling pathway. J Recept Signal Transduct 34(5):396–400. https://doi.org/10.3109/10799893.2014.908916
Wang LL, Huang YH, Yan CY, Wei XD, Hou JQ, Pu JX, Lv JX (2016) N-acetylcysteine ameliorates prostatitis via miR-141 regulating Keap1/Nrf2 signaling. Inflammation 39(2):938–947. https://doi.org/10.1007/s10753-016-0327-1
Sun Y, Pu LY, Lu L, Wang XH, Zhang F, Rao JH (2014) N-acetylcysteine attenuates reactive-oxygen-species-mediated endoplasmic reticulum stress during liver ischemia-reperfusion injury. World J Gastroenterol 20(41):15289–15298. https://doi.org/10.3748/wjg.v20.i41.15289
Guo MY, Wang H, Chen YH, Xia MZ, Zhang C, Xu DX (2018) N-acetylcysteine alleviates cadmium-induced placental endoplasmic reticulum stress and fetal growth restriction in mice. PLoS ONE 13(1):e0191667. https://doi.org/10.1371/journal.pone.0191667
Singh F, Charles A-L, Schlagowski A-I, Bouitbir J, Bonifacio A, Piquard F, Krähenbühl S, Geny B, Zoll J (2015) Reductive stress impairs myoblasts mitochondrial function and triggers mitochondrial hormesis. Biochimica et Biophysica Acta (BBA) 1853(7):1574–1585. https://doi.org/10.1016/j.bbamcr.2015.03.006
Kenny TC, Craig AJ, Villanueva A, Germain D (2019) Mitohormesis primes tumor invasion and metastasis. Cell Rep 27(8):2292–2303.e2296. https://doi.org/10.1016/j.celrep.2019.04.095
Jezek P, Holendova B, Garlid KD, Jaburek M (2018) Mitochondrial uncoupling proteins: subtle regulators of cellular redox signaling. Antioxid Redox Signal 29(7):667–714. https://doi.org/10.1089/ars.2017.7225
Palacio JR, Markert UR, Martinez P (2011) Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages. Inflammation Res 60(7):695–704. https://doi.org/10.1007/s00011-011-0323-8
Victor VM, Rocha M, De la Fuente M (2003) Regulation of macrophage function by the antioxidant N-acetylcysteine in mouse-oxidative stress by endotoxin. Int Immunopharmacol 3(1):97–106
Sadowska AM, Manuel YKB, De Backer WA (2007) Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther 20(1):9–22. https://doi.org/10.1016/j.pupt.2005.12.007
Aldini G, Altomare A, Baron G, Vistoli G, Carini M, Borsani L, Sergio F (2018) N-acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radical Res 52(7):751–762. https://doi.org/10.1080/10715762.2018.1468564
Holmay MJ, Terpstra M, Coles LD, Mishra U, Ahlskog M, Öz G, Cloyd JC, Tuite PJ (2013) N-acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases. Clin Neuropharmacol 36(4):103–106. https://doi.org/10.1097/WNF.0b013e31829ae713
Coles LD, Tuite PJ, Oz G, Mishra UR, Kartha RV, Sullivan KM, Cloyd JC, Terpstra M (2018) Repeated-dose oral N-acetylcysteine in Parkinson's disease: pharmacokinetics and effect on brain glutathione and oxidative stress. J Clin Pharmacol 58(2):158–167. https://doi.org/10.1002/jcph.1008
Filipovic MR, Zivanovic J, Alvarez B, Banerjee R (2018) Chemical biology of H(2)S signaling through persulfidation. Chem Rev 118(3):1253–1337. https://doi.org/10.1021/acs.chemrev.7b00205
Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, Lefer DJ (2009) Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105(4):365–374. https://doi.org/10.1161/CIRCRESAHA.109.199919
Yang G, Zhao K, Ju Y, Mani S, Cao Q, Puukila S, Khaper N, Wu L, Wang R (2013) Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid Redox Signal 18(15):1906–1919. https://doi.org/10.1089/ars.2012.4645
Hourihan JM, Kenna JG, Hayes JD (2013) The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613. Antioxid Redox Signal 19(5):465–481. https://doi.org/10.1089/ars.2012.4944
Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, Kim S, Snyder SH (2012) Hydrogen sulfide-linked sulfhydration of NF-kappaB mediates its antiapoptotic actions. Mol Cell 45(1):13–24. https://doi.org/10.1016/j.molcel.2011.10.021
Untereiner AA, Fu M, Modis K, Wang R, Ju Y, Wu L (2016) Stimulatory effect of CSE-generated H2S on hepatic mitochondrial biogenesis and the underlying mechanisms. Nitric Oxide 58:67–76. https://doi.org/10.1016/j.niox.2016.06.005
Zhang J-Y, Ding Y-P, Wang Z, Kong Y, Gao R, Chen G (2017) Hydrogen sulfide therapy in brain diseases: from bench to bedside. Med Gas Res 7(2):113–119. https://doi.org/10.4103/2045-9912.208517
Arndt S, Baeza-Garza CD, Logan A, Rosa T, Wedmann R, Prime TA, Martin JL, Saeb-Parsy K, Krieg T, Filipovic MR, Hartley RC, Murphy MP (2017) Assessment of H2S in vivo using the newly developed mitochondria-targeted mass spectrometry probe MitoA. J Biol Chem 292(19):7761–7773. https://doi.org/10.1074/jbc.M117.784678
Szabo C, Ransy C, Modis K, Andriamihaja M, Murghes B, Coletta C, Olah G, Yanagi K, Bouillaud F (2014) Regulation of mitochondrial bioenergetic function by hydrogen sulphide. Part I. Biochemical and physiological mechanisms. Br J Pharmacol 171(8):2099–2122. https://doi.org/10.1111/bph.12369
Acknowledgements
MB is supported by a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship (Grant Nos. APP1059660 and APP1156072).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Morris, G., Walder, K.R., Berk, M. et al. The interplay between oxidative stress and bioenergetic failure in neuropsychiatric illnesses: can we explain it and can we treat it?. Mol Biol Rep 47, 5587–5620 (2020). https://doi.org/10.1007/s11033-020-05590-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-020-05590-5